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ABSTRACT
The rise of multi-drug resistant bacteria combined with a decreasing pool of effective
antibiotics has placed an increasing need for the development of novel antibiotics. Bacterial natural
products or secondary metabolites have been the greatest source for development of novel
antibiotics. The genus Burkholderia has recently emerged as a source of promising compounds
with antibacterial, antifungal, and anti-cancer activities. Bacterial secondary metabolites provide
added advantage to bacteria under stressful environments such as during host infection, evading
predators or nutrient deficient conditions. However, genes involved in synthesis of these novel
compounds remain silent under normal laboratory growth, creating a hurdle in isolation and
characterization of these compounds. Understanding the underlying mechanism of how these
genes are regulated could hold the key to unlocking the production of the secondary metabolites.
A large number of biosynthetic gene clusters in Burkholderia thailandensis are known to
be under direct or indirect control of the global regulator, MftR (Major facilitator transport
regulator). MftR, a MarR (Multiple antibiotics resistance regulator) homolog, is conserved even
in the pathogenic strains. My work focuses specifically on the role of MftR in regulation of genes
encoding proteins required for production two secondary metabolites involved in increasing fitness
of the bacteria through increased virulence a) malleilactone, a cytotoxic compound, and b)
malleobactin, the major siderophore. The data presented here indicate that under normal growth
conditions MftR directly represses the expression of genes encoding local activators, MalR and
ECF (extra-cytoplasmic sigma factor), which are essential for production of malleilactone and
malleobactin, respectively. Further, my work shows disruption of the purine metabolic pathway
induced by sub-lethal dosage of trimethoprim in B. thailandensis, and that such disruption leads
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to increased virulence as indicated by increased killing of Caenorhabditis elegans by bacterial
cells grown with trimethoprim. Moreover, disruption of mftR makes B. thailandensis more
virulent as indicated by increased motility, biofilm production, siderophore production, killing of
C. elegans, and rot on onion bulb.
Overall, the work conducted so far not only addresses the role of secondary metabolites,
malleilactone and malleobactin, in virulence of bacterial physiology, but also that targeting a
global regulator could be an effective way of eliciting production of secondary metabolites.
Moreover, the role of a global regulator in increasing bacterial fitness under antibiotic stress
through production of secondary metabolites is highlighted.
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CHAPTER 1
DO GLOBAL REGULATORS HOLD THE KEY TO PRODUCTION OF
BACTERIAL SECONDARY METABOLITES?
INTRODUCTION
A large number of antibiotics are in clinical use, and they target a variety of pathways that
range from cell wall, protein, and DNA synthesis to folate and nucleotide metabolism [1]1. Over
the last decade, occurrences of multiple drug resistant bacteria have been on the rise, and the
development of new effective methods or drugs to combat such strains has become critical [2].
Studies focused on the identification and isolation of novel natural products from microbes that
are effective against pathogenic bacteria or possess other clinical significance, e.g., anti-fungal,
anti-cancer, and immunosuppressant activities, have become a priority [3, 4]. A considerable
number of current pharmaceutical drugs have been directly derived from, or inspired by, bacterial
natural products or secondary metabolites. These secondary metabolites, which are not essential
for growth under normal conditions, are produced by bacteria in response to environmental stress
or host interaction and provide them with a competitive advantage. Many bacterial species produce
bioactive secondary metabolites, of which members of the genus Streptomyces and lately the genus
Burkholderia are prominent sources. Streptomyces is the source of about 80% of the antibiotics
that are produced today, which includes neomycin, kanamycin, vancomycin, streptomycin,
tetracycline, and chloramphenicol [5, 6]. Proteins that are essential for the production of these
bioactive compounds are generally encoded by large cryptic gene clusters, which remain silent
under normal laboratory conditions, a circumstance that creates hurdle in discovery of novel
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This chapter was previously published as Thapa, S.S.; Grove, A. (2019) Do Global
Regulators Hold the Key to Production of Bacterial Secondary Metabolites?
Reprinted (with some modification) with permission from Antibiotics 2019, 8, 160.
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compounds [7, 8]. This review article focuses on such cryptic gene clusters in the genus
Burkholderia and on potential mechanisms for eliciting their expression.
When originally coined in 1992, the genus Burkholderia comprised seven species [9]. At
present, nearly a hundred validly named Burkholderia species exist [10]. These Burkholderia
species occupy diverse ecological niches (free living, saprophytic, obligate endosymbionts,
phytopathogens, opportunistic pathogens, or obligate parasites) and they include species that can
serve as biocontrol and bioremediation agents as well as pathogens. Some Burkholderia species,
mainly B. pseudomallei, B. mallei, and members of the B. cepacia complex (Bcc), have caught
attention because of their pathogenicity [11]. Genome sequencing of Burkholderia spp., driven
largely by a desire to understand virulence mechanisms, has led to the discovery of a large number
of cryptic natural product biosynthetic gene clusters [12]. The regulatory mechanism of some of
these cryptic gene clusters has been studied in detail, primarily in B. thailandensis. B.
thailandensis, which is a relatively non-pathogenic strain, shares a large number of genes with
other members of the B. pseudomallei complex (Bpc), some of which are involved in synthesis of
bioactive compounds.
The B. thailandensis genome features ~22 natural product biosynthetic gene clusters [12,
13]. Understanding how these gene clusters are regulated by local or global regulators (repressors
or activators) and how different stress conditions (such as oxidative stress, osmolarity stress,
phosphate starvation, and amino acid starvation) or inducing ligands can elicit gene expression is
key to unlocking the potential of these cryptic gene clusters. Here, we focus on how the gene
clusters that are responsible for encoding proteins involved in the synthesis of well-characterized
bioactive compounds are regulated by local transcription factors dedicated to a specific gene
cluster and how global regulators exert control over multiple gene clusters. Based on recent reports
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that a multitude of compounds are concurrently produced under conditions such as antibiotic stress
and that the corresponding gene clusters are induced by inactivating a single transcription factor,
we propose that such global regulators hold the key to the discovery of novel compounds.
BIOACTIVE SECONDARY METABOLITES
Malleilactone
Bacterially produced cytotoxic products are an important contributor to pathogenesis
during host infection. To conserve energy, such compounds are only produced when needed and
in response to inducing signals; they are, therefore, generally not synthesized under normal
laboratory conditions, and this renders their identification and characterization particularly
challenging. Malleilactone (also identified as Burkholderic acid [14]), is a polyketide synthase
(PKS)-derived cytotoxic product, produced by species in the B. pseudomallei complex (Bpc), and
it has received much attention, as it has been shown to be essential for B. pseudomallei and B.
thailandensis to cause infection in Caenorhabditis elegans (Figure 1.1). Malleilactone can also
inhibit growth of Gram-positive bacteria and it is cytotoxic to cultured mammalian cells [15-17].
Proteins that are encoded by the mal gene cluster produce it (Table 1.1).
In B. thailandensis, the mal cluster is an ~35 kb cryptic gene cluster with 13 open reading
frames (BTH_II2088 to BTH_II2099). The mal cluster is highly conserved in B. pseudomallei and
B. mallei with about 80–90% amino acid identity across these three species [14, 15] (Figure 2A).
The mal cluster has the same gene content in B. pseudomallei, B. mallei, and B. thailandensis,
except that two annotated hypothetical genes that are upstream of malA and upstream of malC are
absent in B. thailandensis. The mal cluster is divergent from the gene encoding the transcription
factor MalR.
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MalR has been shown to be essential for the expression of the mal cluster, and in both B.
thailandensis and B. pseudomallei, MalR was shown to be required for the bacteria to infect C.
elegans [18-21]. MalR is an orphan LuxR, which means that no cognate LuxI acyl homoserine
lactone (AHL) synthase has been identified. The intergenic region between malR and malA
contains a lux box-like region, to which MalR likely binds, and an intact lux box is required for
the expression of malA, which indicates that MalR functions as an activator [13, 15, 18, 19].
Generally, LuxRs respond to either endogenously and/or exogenously produced AHLs, but MalR
does not respond to AHLs. However, the deletion of all three luxI genes in B. pseudomallei Bp82
led to ~10-fold greater production of Malleilactone, and expression was restored to wild type levels
upon the addition of all three AHLs exogenously to the ∆ culture. This led to the inference that
AHL levels indirectly regulate the production of Malleilactone [19]. As outlined below, the AHLmediated repression is likely achieved via the global regulator ScmR (Secondary Metabolite
Regulator).
Bactobolin
Bactobolin, which is a polyketide-peptide (a C6-polyketide fused to a chlorinated hydroxyvaline residue), is produced by B. thailandensis (Figure 1). It was initially identified and
characterized in Pseudomonas BMG13-A7 (1979 AD), where the compound was shown to have
antibacterial as well as anti-tumor effects [22]. A number of studies have been conducted in
Burkholderia spp. to understand the effect of the compound, its mechanism of action, and the genes
that are involved in its synthesis. Approximately eight structurally different Bactobolin compounds
have been identified in B. thailandensis (Bactobolin A-H) [23]. Bactobolins A-D have been tested
for cytotoxicity to mammalian cells and antibacterial activity, with compounds A and C exhibiting
more antibacterial activity than B and D. Further, there is a direct correlation between cytotoxicity
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Figure 1.1. Chemical structures of selected secondary metabolites. Two-dimensional structures
were obtained from PubChem (Malleilactone under the name Burkholderic Acid), except for
Burkholdac B, which was obtained from ChEMBL (under the name Thailandepsin A) and
Capistruin, for which the three-dimensional structure represents its conformation in complex with
RNA polymerase (PDB ID 6N61). The complete amino acid sequence of Capistruin is
GTPGFQTPDARVISRFGFN, where bold letters denote residues linked by a backbone-sidechain
lactam linkage to form the cyclic structure through which the C-terminal residues are threaded.
Images were rendered with PyMol. C, yellow; O, red; N, blue; H, grey; S, orange; Cl, green.
and antibacterial activity [24]. The compounds seem to be particularly effective against Grampositive bacteria. A mutational study in B. subtilis confirmed that Bactobolin targets the ribosome,
but a different site than other known ribosome inhibitors [24]. Specifically, Bactobolin A’s
biological activity derives from inhibiting protein synthesis by binding to a site in the 50S
ribosomal subunit, which displaces tRNA from the P site of the ribosome [25].
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Genes that are involved in synthesis of Bactobolin have been identified and characterized
for B. thailandensis [24, 26]. It is one of the few gene clusters that include both polyketide synthase
(PKS)-and nonribosomal peptide synthetase (NRPS)-encoding genes (Figure 2B). An ~37 kb gene
cluster, btaA to btaU (BTH_II1222-BTH_II1242), which includes the LuxI-LuxR system btaI2
(BTH_II1227) and btaR2 (BTH_II1231), is involved in the synthesis and regulation of Bactobolin
(Table 1.1) [24, 26]. The gene cluster is relatively conserved in B. pseudomallei, but not in B.
mallei. The btaI2-btaR2 quorum sensing pair is absent in B. mallei (most likely lost due to deletion
of genes not required for virulence) [24, 27]. The presence of the btaI2-btaR2 system in the cluster
suggests that the production of Bactobolin would be regulated in a quorum sensing-dependent
manner, an inference that was confirmed by the generation of a quorum sensing-defective ∆ [28].
That BtaI2 and BtaR2 control the production of Bactobolin has been established while using the
btaR2 ∆, which showed no antibiotic activity against Gram-positive bacteria. It is interesting to
note that btaR2 could also be regulated by the product of BtaI3 [26]. As discussed below, the
expression of genes encoding BtaR2 and BtaI2, and therefore the bta gene cluster, is under the
control of the global regulators ScmR and MftR (Major Facilitator Transport Regulator).
Moreover, the production of Bactobolin has been suggested to be influenced by temperature, as its
production was higher when B. thailandensis was grown at 30 °C as compared to 37 °C [24].
Capistruin
Capistruin belongs to the family of lasso peptides. Lasso peptides are bioactive peptides, which
are ribosomally synthesized and post-translationally modified. They are characterized by an Nterminal macrolactam ring through which a C-terminal peptide tail is threaded [29-31]. The first
lasso peptide, Anantin, was discovered in 1991 from a strain of Streptomyces coerulescens [32].
Capistruin from B. thailandensis was the first lasso peptide to be identified based on a genome
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mining approach. This approach has since led to the more efficient identification of lasso peptides,
and about 50 lasso peptides have been discovered so far. They have been classified into class I
(which contains two disulfide bonds), class II (the most abundant type, which has no disulfide
bonds, but the topology is held by steric hindrance), and classes III and IV (which both contain
one disulfide bond that connects the ring to the tail or is within the tail region, respectively) [33].
Table 1.1 Local regulators of biosynthetic gene clusters.
Bioactive Compound

Gene

Local Regulator

Cluster

Cellular
Target/Function

Malleilactone

mal

MalR (Orphan LuxR)

Unknown

Bactobolin

bta

BtaR2 (LuxR)

50S Ribosomal Subunit

Capistruin

cap

Unknown

RNA Polymerase

Thailandamide

tha

ThaA (Orphan LuxR)

Acetyl-CoA Carboxylase

Burkholdacs

bhc

BhcM (AraC)

Histone Deacetylase

Pyoverdine

pvc

BTH_II2035(LTTR)?

Siderophore

Unknown
Ornibactin

orb

OrbS (ECF)

Siderophore

Thailanstatin

tst

TstA (Orphan LuxR)

Spliceosome
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Capistruin belongs to class II and it is similar to E. coli MccJ25 (Microcin J25; Figure 1). The
mature Capistruin is a 19 amino acid peptide (excised from a 47 amino acid precursor), in which
the N-terminal 9 residues form the macrolactam ring through which the 10-residues long Cterminal tail is threaded [29, 34, 35]. Unlike other antibacterial compounds, Capistruin from B.
thailandensis is effective against closely related Burkholderia and Pseudomonas strains [35].

Figure 1.2. Organization of biosynthetic gene clusters. (A) Malleilactone. (B) Bactobolin. (C)
Capistruin. (D) Thailandamide. (E) Burkholdacs. (F) Pyoverdine. (G) Ornibactin. (H)
Thailanstatin. Genomic loci and individual gene annotations correspond to B. thailandensis E264
and are obtained from the Burkholderia Genome Database (https://www.burkholderia.com),
except for the Ornibactin biosynthetic gene cluster (B. cenocepacia J2315; Burkholderia Genome
Database [36]) and the Thailanstatin gene cluster (B. thailandensis MSMB43; NCBI GenBank
JX307851.1).
This leads to the suggestion that Capistruin-producing Burkholderia species either encode an
immunity protein or feature some modification of the target. Capistruin and Microcin J25
biological activity is due to their ability to inhibit RNA polymerase (RNAP), although for Microcin
J25, the over-production of reactive oxygen species (ROS) through a possible secondary target has
8

also been suggested [37-39]. Microcin J25 and Capistruin share the RNAP secondary channel as
their binding site. Although Capistruin binds to E. coli RNAP as effectively as Microcin J25 in
vitro, a nearly 10-fold higher concentration of Capistruin is required for inhibiting E. coli growth.
Similarly, Microcin J25 can bind Pseudomonas RNAP as effectively as Capistruin, which inhibits
Pseudomonas and Burkholderia growth, but no such inhibitory effect was seen with Microcin J25
[34, 35]. A recently discovered lasso peptide, named Citrocin, which was isolated from Citrobacter
pasteurii and Citrobacter braakii, showed similar effect; the lasso peptide was nearly 100-fold
more potent as an RNAP inhibitor compared to Microcin J25, but a higher concentration of
Citrocin was required to inhibit E. coli growth when compared to Microcin J25 [40]. Despite
having the same functional target, the effect of the compounds seems to be species-specific. The
most likely reason for this species specificity is a variation in cellular uptake/export [34]. Another
plausible cause could be a variation in how the compounds inhibit RNAP. The crystal structure of
Microcin J25 and Capistruin in complex with RNAP has revealed that Microcin J25 binds within
the active site of RNAP, which limits or prevents access to NTPs, and its inhibition of RNAP is
partially competitive with respect to NTP binding. This is not the case for Capistruin, which binds
further away from the active site, its inhibition is partially non-competitive with NTP binding, and
it lowers the rate of phosphodiester bond formation by eight-fold. This suggests that the Capistruinmediated inhibition of RNAP catalysis is primarily due to interference with the proper folding of
the trigger loop, a mobile element within the RNAP catalytic subunit [39].
By comparison to the E. coli MccJ25 gene cluster (mcjABCD), a similar cluster was found
in B. thailandensis and was determined to be the Capistruin biosynthetic gene cluster (capABCD;
Figure 2C). capABCD encodes (i) the capistruin precursor protein CapA (BTH_I2437a), (ii) two
modifying enzymes for converting the precursor to mature lasso peptide, a putative protease CapB

9

(BTH_I2438) and asparagine synthase CapC (BTH_I2439), and (iii) an ABC transporter CapD
involved in export/immunity (BTH_I2440). CapD is most likely involved in the export of
Capistruin from the cell, thereby mediating both transport and detoxification. Overproduction of
the CapD homolog McjD in E. coli was sufficient to establish resistance against Capistruin [41].
The 4.5 kb lasso peptide gene cluster is conserved in B. pseudomallei.
The mechanism of expression of lasso peptide biosynthetic genes is poorly understood
(Table 1.1). The E. coli mcjABCD was shown to be up-regulated under iron deficient conditions
[42]. Similarly, Capistruin production in Burkholderia was upregulated when cells were grown in
minimal media under heat stress (42 °C). Both cases can be related in terms of nutrient deficient
conditions, but if nutrient deficiency were the main trigger for expression, one would expect
Capistruin production to be higher in the stationary phase as compared to the exponential phase.
However, unlike many other secondary metabolites with antibacterial activity, Capistruin can be
detected in exponential phase, and its synthesis is arrested while transiting from late exponential
to early stationary phase [35], which suggests a different mode of regulation as compared to other
biosynthetic gene clusters. While no local regulator has been reported, Capistruin biosynthesis
genes are under the control of ScmR and MftR, as discussed below.
Thailandamide
Thailandamide, which is a linear, long-chain, unstable polyene natural product, is a fatty
acid synthesis blocker (Figure 1.1). It is a broad-spectrum antibiotic that has effect against both
Gram-positive and Gram-negative bacteria. The structure of three distinctive forms of
Thailandamide have been elucidated (Thailandamide A, Thailandamide B, and Thailandamide
lactone). Thailandamide A is effective against Gram-positives, but it is less effective against Gramnegative bacteria (except Neisseria gonorrheae). It is interesting to note that a change in the E.
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coli cell wall structure, which increased uptake, led to an increased efficiency of ThailandamideA. This prompted the suggestion that the otherwise broad-spectrum activity of Thailandamide is
limited by poor uptake in Gram-negative bacteria [43]. A study involving insertional mutation for
characterization of new antibiotics revealed Thailandamide B to be the major product formed by
B. thailandensis [44]; this is contrary to other analyses, where Thailandamide A was shown to be
the major product [43, 45-47]. Thailandamide B was revealed to have bactericidal activity and it
was shown to be toxic to human cells as well. Since Thailandamide is unstable, these differences
might derive from variations in the extraction techniques; alternatively, mutations in genes
encoding regulatory factors could lead to variations in the types of Thailandamide produced. For
example, Thailandamide lactone, which was only detected in cells in which the tha gene cluster
was highly active, displayed moderate anti-proliferative activity against tumor cell lines [46].
B. subtilis is sensitive to Thailandamide, and it was shown that a mutation in the accA gene,
which encodes acetyl-CoA carboxylase, conferred resistance against Thailandamide A. Similarly,
a single base mutation in accA was found in Thailandamide B-resistant Salmonella ∆s. Further, in
B. subtilis, over-expression of ∆ AccA was sufficient to relieve the Thailandamide-induced
inhibition. Thus, the cellular target for Thailandamide was suggested to be AccA protein or the
AccA/AccD complex, which is involved in the first committed step of fatty-acid biosynthesis [43,
44].
The B. thailandensis gene locus BTH_II1662-1681 encodes proteins that are involved in
the synthesis of Thailandamide (BTH_II1662-1676), resistance (BTH_II1679), and regulation of
its production (BTH_II1681/ThaA; Figure 2D). thaC or accA-2 is responsible for resistance
against Thailandamide (B. thailandensis and closely related species are resistant to
Thailandamide). The presence of a second copy of accA (thaC) likely affords the resistance to

11

Thailandamide, which further strengthens the inference that AccA is the target for Thailandamide
[43, 44], as cells that express thaC are less susceptible to Thailandamide activity. It is interesting
to note that several Burkholderia spp., which lack the tha gene cluster still encode a thaC homolog
[43]. This could explain the Thailandamide resistance characteristic of these Burkholderia spp.
The mode of regulation of the tha biosynthetic gene cluster has not been elucidated or
agreed upon completely (Table 1.1). Thailandamide production seems to be regulated by more
than one gene product, and environmental cues appear to be responsible for its regulation. Under
normal growth conditions, only vanishingly small amounts of Thailandamide are produced and
exclusively in the early growth phase. The disruption of thaA (luxR5) abolished production of
Thailandamide A, whereas the disruption of the thaA promoter resulted in increased production,
likely on account of increased thaA expression. ThaA (LuxR5) has an AHL motif and is similar to
LuxR regulators, but it has no known cognate LuxI [46]. In a study that was designed to elucidate
a quorum sensing-controlled regulon in B. thailandensis, it was shown that ThaA is autoregulatory
and represses thaA. Interestingly, thaA was activated upon addition of exogenous AHLs [48].
Whether ThaA directly responds to AHL levels or if thaA is activated by another transcription
factor remains to be determined. Most likely, ThaA activates the expression of genes that are
involved in Thailandamide synthesis. As cells progress from early growth phase, levels of AHLs
increase, which should lead to an increased production of ThaA; therefore, the observed decrease
in Thailandamide production speaks to the repression of the tha cluster by a different mechanism.
As noted below, increased AHL-dependent production of ScmR might explain such repression.
Recently, it has been shown that transposon-mediated disruption of momS (BTH_I0633) led to
increased production of Thailandamide B. MomS has 66% sequence identity to AtsR (Adhesion
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and Type Six Secretion System Regulator), which has been shown to be a global regulator in B.
cenocepacia [44].
Burkholdacs
Burkholdacs belong to the class of histone deacetylase (HDAC) inhibitors, which includes
drugs, such as vorinostat, romidepsin, belinostat, and panobinostat (Figure 1.1). HDACs are a
relatively new class of anti-cancer agents that induce death, apoptosis, and cell-cycle arrest. In
eukaryotic cells, expression of genes is regulated through chromatin remodeling. One of the
mechanisms by which such remodeling can be brought about is through either acetylation or
deacetylation of lysine residues in core histones. While HATs (histone acetyl transferases), as the
name suggests, acetylate the core histones, leading to uncoiled or less compact DNA, providing
access to the transcription machinery, HDACs remove acetyl groups leading to the condensation
of DNA around histone and repression of transcription. Thus, HDAC inhibitors prevent
deacetylation, leading to an accumulation of hyperacetylated nucleosomes and differential gene
expression [49].
Burkholdacs A and B from B. thailandensis were first isolated based on the overexpression of transcription factors linked to genes encoding secondary metabolite biosynthetic
enzymes. In B. thailandensis, the bhc gene cluster includes two adjacent operons BTH_I23572358 and BTH-2359-2367, a hybrid-NRPS/PKS biosynthetic gene cluster (Figure 2E). The gene
cluster has been shown to be under control of BTH_I2369 (encoded by bhcM), an AraC family
transcription factor (Table 1.1) [50]. Members of the AraC/XylS family have three common
regulatory functions: carbon metabolism, stress response, and pathogenesis [51]. Most members
function as transcriptional activators, but some act as repressors or both, depending upon promoter
architecture or the presence or absence of effectors [52, 53].
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The above-mentioned study involving an overexpression of transcription factors within or
adjacent to NRPS/PKS gene clusters identified BhcM as an activator of the bhc gene cluster, but
it did not reveal how bhcM expression is controlled. [50]. Members of AraC/Xyls can be classified
into two groups: Either the signal receptor and regulatory function resides in same polypeptide or
transcription of the regulatory protein is controlled by another regulator, be it repressor or activator
[51]. BhcM seems to fall in the latter group, as discussed below.
Pyoverdines
Pyoverdines, fluorescent yellowish-green pigments, are the primary siderophores in P.
aeruginosa (Figure 1.1). Siderophores are small, metal-chelating molecules with high affinity for
Fe (III), which are produced by almost all bacteria and generally under iron limiting conditions.
The role of siderophores becomes even more critical for pathogens that face a challenging low iron
environment inside a host [54, 55]. Besides acting as iron chelators, siderophores (catecholate
types) can serve an anti-oxidant role during host-pathogen interactions [56]. Siderophores can also
bind other essential metals, such as Mn, Mo, Co, and Ni, and deliver them to the microbe [57].
Various strains of Pseudomonas secrete different Pyoverdines, but commonalities in their structure
include: (i) a fluorescent chromophore that is quenched upon binding of Fe3+, (ii) a strain-specific
peptide that interacts with Fe3+ by chelating it, and (iii) an acyl side-chain bound to the
chromophore whose functionality has not been completely understood [58]. Pyoverdines have
been shown to be involved in both acquisition of iron and as signaling molecules for production
of virulence factors [59-62]. No systematic analyses of Pyoverdine function have been reported in
B. thailandensis. However, a study was carried out to determine the interactions between different
cystic fibrosista pathogens discovered that Pyoverdine produced by P. aeruginosa inhibited the
growth of B. cenocepacia J2315 [63].
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The B. thailandensis chromosome harbors a predicted Pyoverdine gene cluster
(BTH_II0229-0234) that is similar to P. aeruginosa pvcABCD (PyoVerdine Chromophore)
cluster, which encodes proteins needed to synthesize Pyoverdine [17, 64]. In B. thailandensis, a
convergently oriented LysR-type transcriptional regulator (LTTR; BTH_II0235) is encoded
immediately downstream of the cluster (Figure 2F). Similarly, P. aeruginosa pvcABCD has a
convergently oriented ptxR that encodes an activator PtxR, also an LTTR. ptxR has two promoter
sites, of which one is regulated in an iron dependent manner, while the other promoter is ironindependent [65].
pvcABCD expression has been shown to be repressed by presence of iron and to be
positively regulated by the alternate sigma factor PvdS and by the activator PtxR [65, 66]. A ptxR
mutant did not produce detectable Pyoverdine, even under iron deficient conditions, which
suggests that PtxR is an essential activator for expression of pvcABCD in P. aeruginosa [66]. PvdS
synthesis is repressed by another transcription factor, called Fur (Ferric uptake regulator), which
utilizes Fe2+ as a corepressor [67]. A low level of iron causes the dissociation of ferrous ion from
Fur, leading to the derepression of pvdS; in turn, PvdS can possibly facilitate the expression of
ptxR. B. thailandensis encodes PtxR and several extracytoplasmic function (ECF) sigma factors,
whose roles have not been determined. A Fur homolog, BTH_I1206, is also present in B.
thailandensis. Thus, the Pyoverdine gene cluster may be similarly regulated in B. thailandensis as
in P. aeruginosa (Table 1.1).
Ornibactin
Ornibactin, which is a tetrapeptide siderophore with an L-ornithine-D-hydroxyaspartateL-serine-L-ornithine backbone (Figure 1.1), was first identified in B. cepacia [68]. Various strains
of Burkholderia produce Ornibactin, but it has been primarily characterized in members of the
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Bcc. Ornibactin is produced under iron deficient conditions and its expression is completely
inhibited by the presence of more than 15 µM of ferric iron in the media [69]. The function of
Ornibactin, besides being an iron-acquiring molecule, has been established by studies of its
function in different strains of Burkholderia. In B. cepacia, Ornibactin was shown to be critical for
establishing infection in a murine chronic respiratory infection model. Moreover, it was noted that
Ornibactin was critical in adherence and colonization [55, 70]. Evolution of the role of Ornibactin
was highlighted by a study that was conducted in B. contaminans MS14, where the production of
Ornibactin was shown to be critical for the production of an antibacterial compound, which is
effective against a wide range of plant-pathogenic bacteria [71].
The Ornibactin gene cluster, orbA through orbS, has been described in B. cenocepacia
J2315 (BCAL 1688-1702). The gene cluster includes a gene encoding an ECF sigma factor, orbS
(BCAL 1688), whose product OrbS has a high degree of similarity to PvdS (Figure 2G). The
Ornibactin gene cluster contains a promoter region, to which OrbS could possibly bind and thus
activate the expression of the gene cluster. Further, no production of Ornibactin was detected in
an orbS mutant, suggesting that OrbS is an essential activator (Table 1.1). The orbS promoter has
a region to which Fur protein may bind and repress its expression under iron sufficiency [69].
Thus, regulation of Ornibactin synthesis by OrbS and Fur could work in similar fashion as
described for Pyoverdine.
An interesting thing to note in the case of the Ornibactin gene cluster, which is present in
a large number of Burkholderia species, is that it has conserved NRPS genes (orbI and orbJ), but
contains diversity within the genes that are involved in initiation, transport, regulation, and
modification, suggesting the possibility for differential roles and regulation across species, as
exemplified by the antibacterial activity of the B. contaminans MS14-derived Ornibactin [71].
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While Ornibactin has been characterized from members of the Bcc, members of the Bpc produce
the related siderophore malleobactin, with the biosynthetic genes being organized and regulated in
a similar fashion [72].
Thailanstatin
Thailanstatin belongs to the spliceostatin class of natural products, which inhibit the
spliceosome. Four forms of the compound (Thailanstatin A-D; Figure 1.1) have been isolated and
characterized from B. thailandensis MSMB43 [73-75]. Alternative splicing, which is carried out
by spliceosomes, generates an abundance of protein variants, however, cancer cells exhibit
increased splicing levels, mutations in the splicing machinery, and aberrant alternative splicing.
Thus, compounds that belong to the spliceostatin class can serve as potent anti-cancer agents [73,
76].
FR901464, the first natural product of the spliceostatin family, was identified in 1996 from
Pseudomonas sp. No. 2663 (subsequently, 16S rRNA sequence analysis showed the correct
phylogenetic classification to be Burkholderia sp. FERM BP-342117 [77, 78]), and it was shown
to have marked anti-tumor activity [79]. As the compound is chemically unstable, a more stable
methylated derivative, Spliceostatin A, was produced. In vitro assays revealed that Thailanstatin
A, which was shown to be the most potent, could inhibit pre-mRNA splicing as efficiently as
FR901464; moreover, it possesses anti-proliferative activity and it is more chemically stable than
FR901464 [73, 74]. Overall, Thailanstatin A has been shown to be less toxic to normal human
cells and effective against human cancer cells lines. Spliceostatin A and FR901464 target the
splicing factor 3b (SF3b) subcomplex of the U2 small nuclear ribonucleoprotein particle of the
spliceosome, leading to the inhibition of pre-mRNA splicing and causing pre-mRNA leakage to
the cytoplasm [80].
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A gene cluster with homology to the fr9 gene cluster, which encodes proteins that are
required for production of FR901464, was discovered in B. thailandensis MSMB43 and it was
named the tst gene cluster (Figure 2H); this gene cluster is not conserved in closely related species
such as B. thailandensis E264. The tst gene cluster is a 78.1 kb DNA region comprising 15 ORFs
(tstA through tstR). tstA, which is divergently oriented to the rest of the gene cluster, encodes a
LuxR type transcriptional factor with no cognate LuxI within the gene cluster (Table 1.1). TstA
has been suggested to be involved in the regulation of the gene cluster [73]. This genomic locus
and its arrangement is very similar to the mal gene cluster arrangement in B. thailandensis E264
suggesting that TstA could possibly serve as an activator of the gene cluster similar to MalR.
Whether TstA responds to AHL levels or any other ligand has not been reported.
GLOBAL REGULATORS OF BIOSYNTHETIC GENE CLUSTERS
ScmR (Secondary Metabolite Regulator)
As discussed above, dedicated pathway-specific regulators control the expression of many
biosynthetic gene clusters. However, efforts to elucidate mechanisms by which cryptic
biosynthetic gene clusters might be activated have recently led to the discovery of global regulators
with a role in controlling an array of biosynthetic gene clusters. One of these regulators is ScmR,
an LTTR, which has been shown to be involved in the production of various secondary metabolites
in B. thailandensis E264. ScmR is conserved in B. thailandensis (BTH_I1403) with orthologs in
B. pseudomallei and B. mallei. The scmR promoter contains a lux box, and gene expression was
shown to be about two-fold greater when the cells were grown to higher cell density [16, 48, 81].
Moreover, no activation of scmR was seen in a mutant strain that was deleted for all three btaI
genes, and therefore deficient in AHL synthesis. Similarly, a B. pseudomallei Bp82 triple btaI
mutant exhibited ~3-fold lower scmR transcript levels when compared to wild type. Interestingly,
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the B. thailandensis triple btaI mutant featured an increased production of cryptic secondary
metabolites, as also seen in the ΔscmR strain, which suggests that ScmR—and therefore production
of some secondary metabolites—is regulated by quorum sensing. Further, production of AHLs is
drastically reduced in the ΔscmR strain, indicating reciprocal regulation of AHL synthesis by
ScmR. In the B. thailandensis ΔscmR strain, 13 of the >20 predicted biosynthetic gene clusters in
B. thailandensis were differentially regulated [16]. We will focus on the role of ScmR in regulation
of some of the compounds that are discussed above.
The inactivation of scmR leads to a 7- to 13-fold upregulation of genes in the bta cluster,
indicating that ScmR represses the production of Bactobolin [16]. The bta gene cluster is locally
activated by BtaR2, which is induced by AHLs. AHLs are produced at a higher cell density and
they serve to activate both BtaR2 and ScmR. The repression of genes in the bta cluster by ScmR
could therefore be achieved by ScmR binding directly to the btaI2 promoter and repressing
transcription, consistent with the ~5-fold increased expression of btaI2 in ΔscmR, forming a
negative feedback loop that is designed to limit bactobolin production by attenuating activation by
the AHL-dependent BtaR2 (Figure 1.3). Recently, a proteomic profiling of B. thailandensis during
host infection revealed that ScmR is overexpressed in host-associated bacteria; while nine of 11
proteins encoded by genes that are repressed by ScmR were detected at lower levels, as expected,
a Bactobolin biosynthetic enzyme was an exception. BtaC, encoded by BTH_II1224, was
overproduced during infection. This suggests that, at least under infection conditions, Bactobolin
synthesis is not solely determined through ScmR-mediated transcriptional repression [82].
The deletion of B. thailandensis scmR also revealed upregulation of genes involved in
Capistruin biosynthesis, implicating ScmR as a repressor. During the stationary phase, AHL levels
increase and scmR expression has been shown to be higher in presence of AHLs. Thus, the decrease
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in Capistruin production that was observed as cells enter stationary phase might be due to more
efficient repression of Capistruin biosynthetic genes by ScmR [16]. Whether ScmR directly
controls the Capistruin gene cluster or whether it controls the expression of a cluster-specific
regulator remains to be determined.

Figure 1.3. Regulation of biosynthetic gene clusters by Major Facilitator Transport Regulator
(MftR) and Secondary Metabolite Regulator (ScmR). Cluster-specific regulators, where known,
are identified in green. Repression is shown as lines, and activation as arrows. Deletion of mftR or
scmR results in the greatest upregulation of Bactobolin and Burkholdac, respectively, as indicated
by heavier lines. ScmR-mediated activation of Pyoverdine biosynthetic genes is marginal (dotted
line). For ScmR-mediated regulation of the Bactobolin biosynthetic gene cluster, direct repression
of btaI2 was inferred, with BtaR2 reciprocally activating scmR.
The metabolomics analysis showed 61-fold increased production of Burkholdac A in
ΔscmR cells, and the corresponding transcriptome analysis revealed 50- to 135-fold upregulation
of the various genes in the bhc cluster [16]. Further, the complementation of the ΔscmR strain
resulted in reduced production of Burkholdac, as seen in wild type cells, which indicated that
ScmR represses the bhc gene cluster. Among the genes that were upregulated in ΔscmR cells is
BTH_I2369 (bhcM), encoding the AraC-family activator of the bhc gene cluster, BhcM. The
repression of the bhc cluster by ScmR can therefore be explained by its repression of bhcM,
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possibly by direct binding to its promoter, resulting in failure to produce an essential activator. As
AHLs are produced at higher cell density even under normal laboratory settings, which leads to
increased production of ScmR and repression of bhcM, this would result in little to no production
of Burkholdacs under these conditions.
The regulation of Malleilactone production by ScmR seems to be more complex. The
metabolomics analysis of ΔscmR cells showed 210-fold overproduction of Malleilactone A,
previously shown to be essential for the bacteria to cause infection in C. elegans. This
overproduction was supported by the 8- to 18-fold upregulation of the different genes in the mal
gene cluster and by the ~90% worm killing in a span of just 20 minutes when only ~5% of the
worms were killed by wild type B. thailandensis [16]. Complementing the ΔscmR strain with
plasmid-encoded scmR resulted in diminished production of Malleilactone, which verifies that
ScmR acts as a repressor of Malleilactone synthesis. MalR has been established as an essential
activator of the mal gene cluster, yet no change in expression of malR was noticed in the ΔscmR
cells. This led the authors to the suggestion that ScmR possibly competes with MalR for binding
to the mal promoter or that the accumulation of an unknown molecule only occurs in ΔscmR cells
and functions as a MalR coinducer to activate the mal gene cluster further; we favor the first
interpretation as no coinducers for MalR have been suggested in other studies. As discussed below,
the global regulator MftR represses the mal gene cluster by also repressing the malR gene, which
suggests an even more complex regulatory network. In a B. pseudomallei Bp82 ΔscmR strain, only
~4-fold increased production of Malleilactone was reported as compared to wild type cells, and
the production was reduced to wild type levels upon complementing the mutant. In B.
pseudomallei Bp82, malR expression was reported to modestly increase in a mutant deficient in
AHL synthesis and malR transcript levels were two-fold higher in a ΔscmR strain, but only when
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cells were grown to late stationary phase and not in exponential or early stationary phase [16, 19].
While the change in malR expression in the AHL mutant would be consistent with repression of
malR by the quorum-sensing activated ScmR, the growth phase-dependent malR expression in
ΔscmR cells points to regulation by a different mechanism.
Major Facilitator Transport Regulator (MftR)
B. thailandensis encodes 12 annotated MarR (Multiple Antibiotic Resistance Regulator)
homologs, all of which are conserved in B. mallei and B. pseudomallei [83]. Members of the MarR
family are transcription factors that are ubiquitous in the domains bacteria and archaea, and they
have been shown to regulate various biological functions, such as response to environmental stress
(for instance, antibiotic and oxidative stress or a change in pH), regulation of genes that are
involved in virulence, and catabolism of aromatic compounds [84-86]. The genomic locus in which
mftR, BTH_I2391 in B. thailandensis, is divergently oriented to the mftP-fenI operon (BTH_I2392
and BTH_2393) is conserved across members of the Bpc. MftR is a MarR homolog, while MftP
(Major Facilitator Transport Protein) encodes an efflux pump and FenI is a predicted glycosyl
hydrolase. MftR binds to the intergenic region between these divergently oriented genes, thereby
repressing the expression of both mftR as well as the mftP-fenI operon [87].
MftR has been previously classified as a member of the MarR subfamily UrtR (Urate
Responsive Transcriptional Regulator) [87, 88]. Urate and xanthine, which are products of purine
metabolism [8, 89], bind MftR and attenuate its binding to DNA. Urate was predicted to bind MftR
in a pocket that spans the DNA-binding and dimerization regions of the protein, a prediction that
was based on the structure of the homologous urate-binding MarR protein HucR [87, 90]. By
binding in this pocket, the ligand is predicted to reconfigure the disposition of DNA recognition
helices to create a conformation that is unfavorable for DNA binding. Urate is produced by host
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xanthine oxidase in response to bacterial infection at levels that can exceed 200 μM [91], which
suggests that MftR might regulate genes upon host colonization. Indeed, determination of the MftR
regulon by using an mftR knockout mutant revealed differential expression of ~400 genes, such as
genes that are involved in biosynthetic processes, metabolism, and pathogenesis [17]. A total of
331 genes were upregulated, while 70 genes were down-regulated in the ΔmftR strain, which
suggests that MftR is a negative regulator of most genes directly or indirectly under its control.
Notably, a number of large biosynthetic gene clusters encoding various secondary metabolites,
which are not expressed under normal laboratory settings were upregulated in the ΔmftR strain as
well as when B. thailandensis was grown in media containing urate. As urate attenuates MftR
binding to DNA, this observation is consistent with MftR functioning as a global repressor of these
gene clusters, and it identifies urate as a common signal for the production of secondary
metabolites. A proteomics analysis of differential protein accumulation in host-associated B.
thailandensis showed a correlation between overproduced proteins and genes that are upregulated
on the addition of urate, in accord with this interpretation [82]. The gene encoding ScmR is among
those upregulated (2–3-fold) in the ΔmftR strain, whereas the expression of mftR is unaltered on
the deletion of scmR, which indicates that MftR acts upstream of ScmR [16, 17].
As discussed above, secondary metabolite production might be controlled by quorum
sensing via AHL-activated expression of scmR. By contrast, MftR may be important for regulation
of gene expression under conditions of host infection that involve the activation of host xanthine
oxidase and therefore increased urate production. However, gene expression analyses indicate that
these regulatory networks are intricately intertwined. The expression of genes that are involved in
quorum sensing (btaI2-btaR2, btaI3-btaR3) as well as AHL levels are elevated in the ΔmftR strain,
which directly implicates MftR in the quorum sensing circuit [17]. Thus, scmR expression might
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be repressed either by direct binding of MftR to the scmR promoter or—more likely—indirectly
via the MftR-mediated regulation of AHL synthesis (Figure 1.3). Genes encoding Bactobolin,
including btaR2/btaI2, are upregulated ~15-fold on the deletion of MftR or on the addition of urate,
and scmR expression is modestly increased. This suggests that the ScmR-mediated repression of
btaI2 (and in turn the repression of the bta gene cluster) inferred to occur during balanced growth
is bypassed when MftR is absent or the inducing ligand for MftR (urate) is present, and it is
consistent with the overproduction of a Bactobolin biosynthetic enzyme in host-associated B.
thailandensis, even under conditions of increased ScmR levels [82]. As scmR expression is
increased in ΔmftR cells, a viable interpretation is that an activator of btaI2 becomes abundant in
the absence of MftR and competes with ScmR for binding; this activator could potentially be
BtaR2, the expression of which is markedly increased in ΔmftR cells [17].
ScmR represses the expression of the local activator BhcM that is required for expression
of the bhc gene cluster. Both scmR, bhcM and the Burkholdac biosynthetic gene cluster are
upregulated ~two-fold in the ΔmftR strain, an expression pattern that suggests a more complex
mechanism for the control of this gene cluster. The modestly increased expression of the
Burkholdac biosynthetic genes in ΔmftR cells may therefore also derive from the accumulation of
an activator of bhcM that can compete with ScmR for binding.
Expression of the mal and tha gene clusters that are involved in production of Malleilactone
and Thailandamide, respectively, are upregulated two- to four-fold in B. thailandensis deleted for
mftR. Genes encoding the local regulators MalR and ThaA are similarly upregulated in the ΔmftR
strain, which indicates the possibility of direct regulation of these regulators by MftR. Both of
these secondary metabolites and their respective gene clusters are upregulated in a ΔscmR strain,
the mal gene cluster in particular, but no upregulation of the respective local regulators was seen.
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Increased expression of the mal gene cluster in ΔmftR cells could be explained by derepression of
malR, which encodes an activator, while the regulation by ScmR might entail a competition
between ScmR and MalR for the mal promoter, as noted above. A similar mode of regulation may
pertain in the case of thaA, with ScmR more effectively competing with ThaA for the regulation
of the tha gene cluster when thaA is repressed by MftR.
Several genes that were upregulated in B. thailandensis ΔmftR cells encode proteins that
are involved in the production and transport of siderophores (Figure 1.3). This includes the gene
clusters linked to production of Pyoverdine (BTH_II0229-0234) and the Ornibactin-like
siderophore Malleobactin (BTH_I2414-2427). The mechanism of regulation of the Pyoverdine
gene cluster remains unknown; specifically, we note that the convergent gene encoding a predicted
LTTR activator of this gene cluster is not differentially expressed on the deletion of mftR [17]. The
expression of genes in this gene cluster is modestly (<two-fold) lower in ΔscmR cells, which
suggests moderate activation by ScmR. By contrast, the ECF sigma factor encoded as part of the
Malleobactin gene cluster (BTH_I2427), which is predicted to activate expression based on
comparison to the P. aeruginosa homolog PvdS, is upregulated in ΔmftR cells as well as in ΔscmR
cells. Whether the gene encoding this sigma factor is directly or indirectly regulated by either MftR
and/or ScmR has not been reported. This ECF is unlikely to participate in the activation of the
Pyoverdine biosynthetic genes, as its upregulation in ΔscmR cells would have been expected to
result in an increased expression of this gene cluster.
TRIMETHOPRIM AS AN INDUCER OF CRYPTIC BIOSYNTHETIC GENE CLUSTERS
Genome mining has advanced the discovery of cryptic biosynthetic gene clusters and
prompted efforts to optimize production of bioactive secondary metabolites. A variety of
approaches, such as changes in fermentation conditions (media composition, temperature, and pH),
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co-cultivation, deletion of local regulators, and random insertional mutagenesis, have been
successfully employed for the isolation and characterization of specific compounds in
Burkholderia spp. For instance, production of Capistruin was greatly enhanced by growing B.
thailandensis in M20 medium at 42 °C, while the isolation of Thailanstatin was optimized by
growing cells in defined fermentation medium [34, 35, 73, 74]. The production of siderophores
was favored by growing the bacteria in iron deficient media or by cocultivation, and Malleilactone
and Thailandamide were isolated as a result of an inducible promoter exchange strategy [15, 44,
71, 92]. Such approaches have been inspired by the successful production of bioactive compounds
from streptomycetes, which are well known as sources of clinically relevant compounds. In these
species, strain development and metabolic engineering approaches have also been implemented
for the improved production of select compounds [93]. While promising, metabolic engineering
remains challenging, due to unintended consequences of competing pathways or the accumulation
of toxic pathway intermediates.
In general, engineering approaches, including expression in heterologous hosts, have
focused on the production of specific compounds. In contrast, chemical elicitors that create a
stressful environment for the bacteria have the potential to induce the expression of multiple
biosynthetic gene clusters. The activation of cryptic gene clusters by small molecules or ligands
may not only increase the yield of individual compounds, but it is also a time and cost-saving
technique by comparison to the more laborious culture optimization or systems metabolic
engineering approaches [94, 95]. Notably, a recent study that was focused on discovering novel
elicitors of cryptic biosynthetic gene clusters in B. thailandensis found that, among the 640
candidates tested, a sub-lethal dosage of the antibiotic trimethoprim was the most potent elicitor
[13]. It should be noted that a cocktail of trimethoprim and sulfamethoxazole (Co-trimoxazole) is
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a therapeutic drug prescribed for the treatment of Burkholderia infections [96, 97]. Metabolomic
profiling of cells that were treated with trimethoprim showed an upregulation of over 100
compounds,

including

molecules

related

to

Capistruin,

Malleilactone,

Burkholdac,

Thailandamide, and Bactobolin. Trimethoprim is a dihydrofolate reductase inhibitor, which
prevents the conversion of dihydrofolate to tetrahydrofolate, a one-carbon donor that is essential
in a variety of biosynthetic reactions, including the production of glycine, methionine, thymidine,
and purines [98]. For trimethoprim to bind all of the structurally different, pathway-specific
regulators of these cryptic biosynthetic gene clusters to induce gene expression would be unlikely.
A more plausible scenario would be for trimethoprim or a metabolite that accumulates in cells
treated with this antibiotic to modulate the function of a global regulator. Indeed, a correlation
exists between the compounds that were detected on the addition of trimethoprim and the gene
clusters upregulated when B. thailandensis is grown in media with urate added. However, for
MftR, it has already been shown that trimethoprim does not directly bind to modulate DNA
binding, and neither does 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an
intermediate in de novo purine biosynthesis shown to accumulate in the presence of trimethoprim
[13, 17]. Thus, the inducing ligand, which accumulates in cells grown with trimethoprim, has yet
to be discovered.
A recent article has reported that homoserine, a precursor in methionine biosynthesis, is
accumulated under the effect of trimethoprim and that it is responsible for the over-production of
malleilactone. The mechanism by which homoserine could lead to over-production of not just
malleilactone, but other secondary metabolites as well was not considered. The experimental
approach used to test if homoserine could bring about a similar effect as trimethoprim relied on
the usage of a very high concentration of homoserine (5 to 10 mM) [99]. Homoserine is first
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converted to homocysteine whose accumulation has been shown to be detrimental in bacteria,
yeast as well as humans [100-102]. An excessive amount of homoserine could thus syphon away
THF necessary for the de novo purine bio-synthesis and other pathways in an effort to convert
homocysteine to methionine, a reaction that requires 5-methyl THF, to prevent accumulation of
the toxic homocysteine. That trimethoprim-mediated inhibition of folate synthesis negatively
impacts de novo purine biosynthesis is well-established. In fact, in yeast excessive accumulation
of homocysteine has been shown to cause a defect in purine biosynthesis [102]. Thus, it remains a
possibility that an excessive amount of homoserine in the media could impact the THF level similar
to trimethoprim and mimic the effect of trimethoprim rather than being the metabolite that is
directly responsible for the accumulation of malleilactone.
CONCLUSIONS AND FUTURE OUTLOOK
Secondary metabolites confer a competitive advantage to bacteria in a hostile environment,
including the inhospitable environment that is created by host defenses, yet the mechanisms that
regulate their production have not been completely deciphered. The gene clusters that encode
enzymes responsible for the production of these secondary metabolites, whether being harmful
virulence factors or novel compounds with potential clinical activity, such as antibiotics, generally
remain silent or cryptic to conserve cellular resources. Understanding how the expression of these
gene clusters is elicited could shed light on mechanisms of pathogenicity as well as advance the
discovery of novel beneficial compounds. The identification of global regulators, which control
cryptic biosynthetic gene clusters, has opened a possible path towards achieving these goals.
Global regulators have previously been shown to be involved in the regulation of
specialized genes, such as those that are involved in pathogenesis, quorum sensing, and biofilm
formation. Increased biofilm formation, which also aids in bacterial antibiotic resistance, is a
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characteristic of the ΔscmR strain. In a similar vein, increased anaerobiosis has been reported for
the ΔmftR strain, a metabolic state that is critical for the survival of bacterial species in an oxygendeprived environment, such as the interior of a biofilm and abscesses that are caused by infection.
A role for both ScmR and MftR in virulence is further supported by their regulation of genes
encoding enzymes that are responsible for the production of siderophores, which become critical
in the iron-deficient environment inside a host [16, 17, 103, 104]. These findings not only suggest
that global regulators can control bacterial fitness in a host environment and increase their
antibiotic resistance, but they also suggest global regulators as suitable targets for drugs. A recent
study in P. aeruginosa showed that the global regulator MvfR (also known as PqsR), an LTTR, is
involved in biofilm formation. A drug (M64) targeting MvfR interfered with biofilm formation of
P. aeugronoisa and increased the antibiofilm activity of other antibiotics when used in conjunction
with M64 [105].
The secondary metabolites that are discussed above likely represent just the tip of the
iceberg and additional, novel secondary metabolites isolated from Burkholderia spp. await
characterization. Inactivation of the global regulators ScmR and MftR is associated with
remarkable changes in secondary metabolite production and a corresponding induction of
biosynthetic gene clusters. Based on these observations, we predict that identifying global
regulators in other bacterial species and understanding their regulatory mechanisms through a
combination of genome-wide transcriptomics, metabolomics, and ChIP-Seq may enhance our
chances of discovering potentially bioactive compounds as well as novel drug targets for
pathogenic strains.
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CHAPTER 2
IMPAIRED PURINE HOMEOSTASIS PLAYS A PRIMARY ROLE IN
TRIMETHOPRIM-MEDIATED INDUCTION OF VIRULENCE GENES IN
BURKHOLDERIA THAILANDENSIS
INTRODUCTION
The genus Burkholderia comprises about 100 species, which occupy diverse ecological
niches (free living, saprophytic, obligate endosymbionts, phytopathogens, opportunistic
pathogens, or obligate parasites)2. Some of these species have potential for use as bioremediation
or biocontrol agents, but the genus is primarily known for the pathogenic strains, namely B.
pseudomallei, B. mallei and the closely related B. cepacia complex (Bcc) species [1, 2]. B.
thailandensis is a relatively nonpathogenic strain, which has been used as a model to study
mechanisms of gene regulation and virulence in B. pseudomallei and B. mallei. Due to high genetic
similarity between these species, they have been classified together as the Burkholderia
pseudomallei complex (Bpc) [3, 4]. B. pseudomallei and B. mallei cause melioidosis and glanders,
respectively, potentially fatal diseases that occur in animals as well as humans. No effective
vaccination has been developed against these diseases, and only few antibiotics are effective for
treatment [5]. One of the most commonly prescribed anti-bacterials for treatment of glanders and
melioidosis as well as Bcc infections is co-trimoxazole, a cocktail of trimethoprim and
sulfamethoxazole [6-8]. Trimethoprim is an antifolate, which inhibits dihydrofolate reductase
(DHFR), the most well-characterized consequence of which is inhibition of thymidine
biosynthesis, leading to “thymine-less” death in bacteria [9, 10]. Folate metabolism is generally
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required for one-carbon (1C) metabolism, and its inhibition interferes with transfer of 1C units in
biosynthetic processes, including purine and thymidine synthesis and amino acid homeostasis [11].
Recently, a metabolomic study in B. thailandensis revealed that a sub-lethal dose (30 µµM)
of trimethoprim causes accumulation of a large number of secondary metabolites that are not
produced under normal laboratory growth conditions, including malleilactone [12]. Secondary
metabolites are often synthesized by products of large biosynthetic gene clusters that remain silent
until induced by elicitors generated under specific conditions. Secondary metabolites, which are
generally produced in response to environmental stress or host interaction provide a competitive
advantage to the bacteria [13, 14]. The trimethoprim-mediated increase in malleilactone
production was ascribed to accumulation of homoserine, a precursor in the methionine biosynthetic
pathway, but the mechanism by which homoserine in turn leads to malleilactone production
remains unknown [15]. Notably, many gene clusters associated with the trimethoprim-induced
metabolome are also repressed by MftR (Major Facilitator Transport Regulator), a MarR (Multiple
Antibiotic Resistance Regulator) homolog [3, 13, 16]. This correlation raises the possibility that
trimethoprim or a metabolite produced when cells are grown with this antibiotic functions as ligand
for MftR; like many MarR family proteins, DNA binding by MftR is relieved on ligand binding,
resulting in upregulation of target genes [3, 17]. However, while two intermediates of purine
metabolism, urate and xanthine, are ligands for MftR, trimethoprim is not. Neither is 5aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR), an intermediate in de novo
purine biosynthesis, which accumulates on inhibition of DHFR [16, 18-20]. As noted above, purine
homeostasis is expected to be impacted by antifolates such as trimethoprim, pointing to a link
between trimethoprim and ligands for MftR.
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MftR is a master regulator in B. thailandensis and disruption of mftR leads to differential
expression of ~400 genes. In general, MftR functions as a repressor as 331 of these genes are
upregulated in an mftR knockout mutant. These include genes involved in metabolic pathways,
production of secondary metabolites, and virulence [16]. Interestingly, the secondary metabolites
that accumulate in B. thailandensis under the effect of trimethoprim correspond strikingly to genes
that are upregulated when the MftR ligand urate is added to the growth media. Among such
accumulated products and upregulated genes is malleilactone and the mal gene cluster.
The mal gene cluster, comprising malA to malM, encodes enzymes essential for production
of the polyketide malleilactone. This 35 Kb region is largely conserved in Bpc members, which
have diverse lifestyles (saprophyte, opportunistic pathogen or obligate parasite) suggesting that
mal gene products are useful in diverse environments. Further, a functional mal gene cluster has
been previously shown to be essential for B. thailandensis to infect Caenorhabditis elegans [21].
The mal gene cluster is under the control of MalR, an orphan LuxR, which is an essential activator
for malleilactone production as a malR mutant showed no detectable production of malleilactone,
even in the presence of trimethoprim or homoserine [15, 22]. B. thailandensis MalR is not a typical
LuxR in the sense that it is not responsive to AHLs (Acyl-Homoserine Lactones) [22, 23]. MalR
and malleilactone are also important virulence factors in B. pseudomallei, and trimethoprimmediated induction of malR expression is conserved [24].
We show here that trimethoprim induces accumulation of the MftR ligand xanthine, which
leads to derepression of malR, and that malR is directly regulated by MftR. Increased expression
of malR in turn correlates with overexpression of the mal gene cluster and with increased virulence
in C. elegans. Since upregulation of the mal gene cluster is greater on addition of trimethoprim
than in an mftR mutant, we propose that malR expression is repressed by both MftR and by a
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separate transcription factor, which also responds to a metabolite that accumulates on exposure to
trimethoprim.
EXPERIMENTAL PROCEDURES
Growth Media and Stock Solutions
Bacterial cells were grown in LB (Luria Broth) media. Trimethoprim (100 mM) was
dissolved in dimethyl sulfoxide (DMSO). Colony morphology was assessed on LB agar containing
Congo Red (40 mg/L). C. elegans assay was performed on 60 mm NGM (Nematode Growth
Media) plates. C. elegans (Bristol strain N2) were maintained at room temperature on NGM media
with E. coli OP50 as the food source. For qRT-PCR (quantitative Real Time PCR), xanthine and
urate assays, and growth analysis, cells were grown in 2×YT media. An overnight culture was
diluted 1:100 for subculture unless indicated otherwise. Allopurinol and xanthine were dissolved
in 0.4 M NaOH and used at final concentrations of 5 mM and 2 mM, respectively. B. thailandensis
E264 strain was obtained from American Type Culture Collection (ATCC).
Growth Analysis
Cells grown overnight were diluted 1:100 in 50 ml 2×YT media and were grown at 37 °C
with constant shaking until OD600 reached ~0.2. At that point, trimethoprim, NaOH, or NaOH plus
trimethoprim was added to the respective flasks and OD600 was recorded every two hours for a
total of 10 hours. Growth curves represent means of triplicate cultures.
Colony Morphology
Colony morphology was performed as described previously with some modifications [16,
25]. An overnight culture of B. thailandensis was diluted 1:100 in 50 ml LB media and placed in
a shaker at 37 °C until OD600 reached approximately 2.0. One ml of the culture was added to a
microcentrifuge tube and centrifuged at 13,000 RPM for 1 min. The supernatant was discarded,
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and the cell pellet was washed with 1 ml of LB. Cells were resuspended in 200 µl of LB and 10 µl
of the suspension was spotted on Congo Red-LB agar plates with or without 25 µM trimethoprim.
Plates were allowed to dry and placed at 37 °C for 4-5 days before taking pictures. The experiment
was performed with three independent cultures.
C. elegans Survival Assay
Ten µl of E. coli OP50 or B. thailandensis grown overnight was spotted on NGM
(nematode growth medium) plates containing DMSO or trimethoprim (25 µM). Plates were
incubated at 37 °C for 24 hours and then allowed to equilibrate to room temperature for 12 h. At
the end of the 12 h period, about 10-12 C. elegans (L4 larval stage) were added to the plates and
left for 24 h at room temperature before determining survival. Worms were observed under a
dissecting microscope (Olympus SZ-ST) for their ability to maintain body posture and sensitivity
to touch. Worms that were completely insensitive to touch and had lost their ability to maintain
normal body posture were declared as dead. The percentage of surviving worms was calculated
as: Survival (%) = (live worms/total worms used) × 100. The experiment was performed with three
separate biological samples, each in triplicate.
Urate and Xanthine Assays
Cellular concentrations of urate were determined using the Amplex Red
Urate/Uricase Assay (ThermoFisher, Waltham, MA) as per the user manual. An overnight culture
of B. thailandensis was diluted 1:100 in 50 ml 2×YT media and placed in a shaker at 37 °C. Once
OD600 reached 0.2, trimethoprim (25 µM) or allopurinol (5 mM) was added to the respective flasks
and cultures were grown until OD600 reached ~0.6. Forty ml of the culture was centrifuged at 3,500
RPM at 4 °C for 8 minutes and the supernatant was discarded. Cells were resuspended in 1 ml of
1× reaction buffer from the assay kit and centrifuged at 13,000 RPM at 4 °C for 1 minute and the
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supernatant was removed. Cells pellets were washed again with the 1× reaction buffer and stored
at -80 °C. Cells pellets were thawed on ice and resuspended in 1 ml of 1× reaction buffer and lysed
by sonication (30% output, pulse mode, total time 10 seconds, 1 minute in ice between each cycle,
8 cycles in total). Sonicated samples were then centrifuged at 13,000 RPM at 4 °C for 10 minutes
and the lysate was transferred to a clean tube. The lysate was centrifuged again for another 3
minutes to remove any transferred residual debris and this cell free lysate was utilized for the assay.
Three hundred µl of the lysate was mixed with 300 µl of the reaction mix (prepared as per the kit
protocol) in a microcentrifuge tube and placed at 37 °C in a well-covered box to avoid light
interference. The absorbance at 560 nm was recorded after 1.5 h. Urate levels were normalized
using the total protein concentration measured at 280 nm. The results obtained are the mean (SD)
from three independent experiments.
Determination of xanthine concentrations was performed utilizing the Amplex Red
Hypoxanthine/Xanthine assay kit (ThermoFisher) as per the user manual. The assay was
conducted, and data were analyzed as described above. Note that determination of xanthine
concentrations requires addition of xanthine oxidase from the assay kit, and cells pellets from
cultures grown with xanthine were therefore washed more extensively.
qRT-PCR
An overnight culture of B. thailandensis was sub-cultured in 50 ml 2×YT media and grown
until OD600 reached ~0.2. Trimethoprim (25 µM), allopurinol (5 mM), a cocktail of allopurinol and
trimethoprim, and/or 0.4 M NaOH (800 ml) was added to the cultures and cells were grown until
OD600 reached ~0.6. Once cells reached this density, 1 ml of the cell culture was pelleted and
washed twice with autoclaved diethyl pyrocarbonate (DEPC)-treated water and stored at -80 °C.
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RNA was extracted utilizing illustra RNAspin mini kit (GE Healthcare, Chicago, IL)
according to the manufacturer’s protocol. RNA was electrophoresed on agarose gels to ascertain
integrity and PCR was performed to verify absence of genomic DNA contamination. Five hundred
ng of RNA was used for preparation of cDNA using AMVRT (Reverse Transcriptase; New
England Biolabs, Ipswich, MA) and gene-specific primers (Supplemental Table S1). Quantitative
PCR was performed on Applied Biosystem QuantStudio 6 Flex System using SYBR Green I dye
and Luna qPCR master mix (New England Biolabs). Expression of the HGPRT gene was utilized
as reference. For measuring expression of XDH, One-Step qPCR was done using Luna One step
universal master mix (New England Biolabs). Data represent means (± SD) from biological
triplicates (each determined from technical triplicates) using the comparative CT method (2-ΔΔCT).
Table 2.1 Primers used for qRT-PCR
Primers

Sequence (5' to 3')

malA forward

GACGATCACCCGGACCTT

malA reverse

TCGATCAGCCAGTCGATGAG

malR forward

GGTCTTCAGCGGTCTTTCG

malR reverse

CGAAGTTCTTGAAGCCCAGT

xdh forward

GATCTGGGCGACGTGCTGTA

xdh reverse

ATCAGGCCCGGCATCGAATC

mftP forward

TGCCCATGCTTAATTCTCCT

mftP reverse

GATCGGCAAGGTCGTCAG

hgprt forward

CGAGAAGAAGCCCTCCACAT

hgprt reverse

TCGAACTCGAGCGGGAAATC
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ChIP Assay
A synthetic DNA construct was used to create a C-terminally FLAG-tagged MftR strain; a
379 bp fragment comprising 292 bp of MftR coding sequence immediately followed by sequence
encoding the 3×FLAG tag and flanked by XbaI and XhoI restriction sites was obtained (Synbio
Technologies, Monmouth Junction, NJ) in the pUC57-Amp vector. The fragment was subcloned
into the mobilizable suicide vector pKNOCK-Tc [26] and transformed into E. coli SM10 λ pir. B.
thailandensis E264 encoding genomic MftR-FLAG was created through biparental mating and
transformants selected as described [16]. Presence of the correct sequence was verified by PCR
(for primers, see Table 2.2) and sequencing.
For ChiP, an overnight culture of B. thailandensis MftR-FLAG was diluted 1:100 in 50 ml
LB. Once the cells reached OD600~0.6, 1% formaldehyde was added to the flask, which was placed
on a shaker for 16 minutes to allow crosslinking to occur. The cell culture was then centrifuged at
3,500 RPM at 4 °C for 8 minutes and the supernatant was discarded. Cell pellets were washed
twice by adding 20 ml phosphate buffered saline (PBS) followed by another wash with 5 ml of
PBS and centrifuging at 3,500 RPM for 5 minutes. Finally, the pellets were resuspended in 1 ml
of PBS and the supernatant was removed after centrifuging at 13,000 RPM for one minute. Cell
pellets were stored at -80 °C. ChIP was performed as previously described with some
modifications [27]. Briefly, cells were suspended in 1 ml of lysis buffer with protease inhibitor
cocktail and placed on ice for 1 hour. Genomic DNA was sheared by sonicating 5 times at 35%
output at 10 secs pulse with 1-minute gap in between. Cell/cell debris-free lysate was collected by
centrifugation at 13,000 RPM at 4 °C for 12 min and transferred to a clean tube. The lysate was
centrifuged for another 3 min and the final lysate was collected. The lysate was precleared using
protein G-Sepharose beads (GE Healthcare) to reduce non-specific binding to the beads. For
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immunoprecipitation, 5 μl of anti-FLAG (M2; MilliporeSigma, Burlington, MA) antibodies was
used. Eluted DNA from ChIP samples or input DNA was analyzed by PCR (for primer sequences,
see Table 2.2). PCR products were electrophoresed on 1.5% agarose gels containing ethidium
bromide. Signal intensities from PCR data was quantified from the TIFF images by using ImageJ
software. Experiments were performed in triplicate.
Table 2.2 Primers used for ChIP and FLAG-tagging.
Primers

Sequence (5' to 3')

mftP-mftR intergenic region chip forward

GAGCTGCGCGATCCATTAAC

mftP-mftR intergenic region chip reverse

TGCAGGAGAATTAAGCATGGG

malR upstream forward

GGTCTTCAGCGGTCTTTCG

malR upstream reverse

CGAAGTTCTTGAAGCCCAGT

ohrR upstream forward

GGTCGTCTCCCATCGTTTC

ohrR upstream reverse

GTCGTTCATGGCGAGATTTTC

Flag-tag cloning verification forward

AACGCACTGAGAAGCCCTTA

Flag-tag cloning verification reverse

TTGCGGAGAACTGAATGC

Flag-tag chromosomal integration

GTCGTCGATGATCGTGCTC

verification forward

Flag-tag chromosomal integration

TTGCGGAGAACTGTGAATGC

verification reverse
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Statistical analyses
For determination of statistically significant differences (gene expression, cellular
urate/xanthine levels, and worm survival), an unpaired, Student’s t-test was used.
RESULTS
Sub-lethal dosage of trimethoprim leads to upregulation of virulence genes
The trimethoprim-induced accumulation of secondary metabolites such as malleilactone
points to a modulation of numerous metabolic pathways and consequently an altered physiological
state. While wild type B. thailandensis grown on LB-Congo Red plates have a rugose morphology,
cells grown on plates with 25 µM trimethoprim gave rise to a smooth colony morphology (Fig.
2.1A-B). A rugose colony morphology is associated with increased surface area, which enhances
access to oxygen and serves to balance cellular redox homeostasis [28]. The 25 µM concentration
of trimethoprim used for our experimental purpose did not arrest cell growth but led to a reduced
growth rate compared to cells grown in LB without the antibiotic (Fig. 2.1C).
MalR is an essential activator of the mal gene cluster, binding to a Lux-box immediately
upstream of malA (Fig. 2.1D), and it is required for trimethoprim-based activation of the mal genes,
a requirement that was inferred to reflect trimethoprim-mediated upregulation of malR [15, 21, 22,
24]. To verify that the sub-lethal (25 µM) dose of trimethoprim caused upregulation of malR and
malA, (encoding the first ORF in the mal gene cluster) relative transcript levels of malR and malA
were measured in wildtype cells grown in liquid culture with trimethoprim. Consistent with
expectations, malR was upregulated ~11-fold in cells grown with trimethoprim compared to cells
grown without trimethoprim, and malA expression increased ~50-fold when cells were grown with
trimethoprim (Fig. 2.1E). Trimethoprim-based upregulation of malR and the mal gene cluster has
been reported in B. pseudomallei as well [24].
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Figure 2.1. Effect of trimethoprim on growth of B. thailandensis. (A-B) Colony morphology of
cells grown on LB-Congo Red plates without (A) or with trimethoprim (B). (C) Growth of cells in
2×YT without (blue line) or with trimethoprim (25 µM; orange line). (D) Intergenic region
between the divergently encoded malR and the mal gene cluster; only part of malA is shown. The
Lux-box to which MalR binds is identified (green line). (E) Increase in expression of malA and
malR induced by addition of 25 µM trimethoprim to liquid cultures. The transcript levels were
calculated using 2-ΔΔCT relative to the reference gene and reported relative to expression in the
corresponding unsupplemented (2×YT) cultures. Asterisks indicate statistically significant
differences (**, p<0.01) based on a Student’s t-test
Xanthine accumulates in cells grown with trimethoprim
We have previously reported that urate elicits an upregulation of malR and the mal gene
cluster, suggesting the possibility that the changes in purine homeostasis expected on treatment
with trimethoprim include elevated urate levels [16]. While xanthine is an intermediate in purine
salvage, its conversion to urate diverts purines away from salvage pathways for complete
degradation (Fig. 2.2A) [18, 19]. A coupled enzymatic assay was performed to determine the
cellular urate level in cells grown with or without trimethoprim, and we found that urate levels
decreased by ~0.6-fold in cells grown with trimethoprim compared to cells grown without
trimethoprim (Fig. 2.2B). This outcome not only suggests that purine degradation may be
disfavored under conditions of trimethoprim-mediated inhibition of DHFR, and hence inhibition
of de novo purine biosynthesis (Fig. 2.2A), but it also indicates that urate is unlikely to be involved
in differential gene expression on exposure to trimethoprim. We also determined the intracellular
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level of xanthine in cells grown with or without trimethoprim by utilizing a similar coupled
enzymatic assay and found it to be increased ~2-fold in cells grown with trimethoprim compared
to cells grown without trimethoprim (Fig. 2.2C). These results make intuitive sense as degradation
of xanthine to urate would prevent recovery of purines through purine salvage (Fig. 2.2A), a
pathway that would likely be favored in response to trimethoprim-mediated inhibition of de novo
synthesis.

Figure 2.2. Trimethoprim alters cellular levels of intermediates in purine metabolism. (A) Outline
of purine salvage pathway in B. thailandensis (several intermediate steps have been omitted for
simplicity). Pathway is represented based on the KEGG pathway database
(https://www.genome.jp/keggbin/show_pathway?org_name=bte&mapno=00230&mapscale=&s
how_description=show). Trimethoprim interferes with de novo synthesis (red arrow), and purine
salvage is expected to be favored on inhibition of de novo synthesis; red arrows next to urate and
xanthine reflect observed changes in cellular level of the indicated metabolite on addition of
trimethoprim. (B-C) Relative cellular urate (B) and xanthine levels (C) in B. thailandensis grown
with trimethoprim compared to cells grown without trimethoprim, reported as mean ± SD from
three independent experiments. Asterisks indicate statistically significant differences (**, p<0.01;
*, p<0.05) for cells grown in media with trimethoprim compared to cells grown without
trimethoprim.
To address the potential role of xanthine in gene regulation, relative expression levels of
malA and malR were measured in cells grown with or without xanthine. An ~4-fold upregulation
of malA and ~2-fold increase in malR expression was seen upon addition of xanthine to the media
(2 mM) (Fig. 2.3A), suggesting that accumulation of xanthine leads to upregulation of malA and
malR. The relatively modest increase in expression of malA and malR seen upon addition of
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xanthine could be the result of a) xanthine (which is dissolved in 0.4 M NaOH) being poorly
soluble and precipitating due to the decrease in pH upon addition to the growth media, b) uptake
of xanthine possibly being inefficient, and c) excess xanthine being easily metabolized in an
unstressed cell. Combined, these factors would work to reduce the xanthine concentration within
the cell. We also note that malR and malA expression is increased 2.5-fold and 5-fold, respectively,
based on RNA-seq data on exposure to 5 mM of the also poorly soluble and readily metabolizable
urate, levels of induction that are comparable to those seen here with xanthine, and that equivalent
urate-mediated increases in gene expression are not observed in ∆mftR cells [16]. Taken together,
our results indicate that xanthine accumulation may contribute to the increased expression of malR
and malA on exposure to trimethoprim and that it may do so, at least in part, by acting as a ligand
for MftR.

Figure 2.3. Modulation of purine metabolism is linked to changes in mal gene expression. (A)
Increase in malA and malR expression induced by addition of 2 mM xanthine. (B) Relative cellular
urate content in B. thailandensis grown with trimethoprim (Tri; 25 µM) or allopurinol (Allo; 5
mM). (C) Relative cellular xanthine content in B. thailandensis grown with trimethoprim (Tri),
allopurinol (Allo), xanthine (Xan) or Trimethoprim + Allopurinol (Tri+Allo). (D) Increase in malA
and malR expression induced by addition of allopurinol. All data are reported as mean ± SD from
three independent experiments. The transcript levels were calculated using 2-ΔΔCT relative to the
reference gene and reported relative to expression in the corresponding unsupplemented (2×YT)
cultures. Asterisks indicate statistically significant differences relative to unsupplemented cultures,
except where bracket indicates otherwise (**, p<0.01; *, p<0.05).
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Xdh inhibition leads to derepression of malR and malA
The enzyme that converts xanthine to urate is xanthine dehydrogenase (Xdh), whereas
xanthine can be produced by the actions of either Xdh or guanine deaminase (Fig. 2.2A).
Allopurinol, a competitive inhibitor of Xdh, is clinically utilized for treatment of gout, which is
caused by accumulation of uric acid crystals [29], and it functions in several bacterial species to
block Xdh activity [30-32]. Allopurinol not only inhibits conversion of xanthine to urate, but an
adverse effect of allopurinol in humans is the accumulation of xanthine [33, 34]. Thus, allopurinol
could possibly mimic the effect of trimethoprim by promoting an accumulation of xanthine. To
evaluate this possibility, 5 mM allopurinol was added to the growing culture when the cell density
reached OD600~ 0.2, and the cellular urate level was measured. We found that allopurinol mediated
a decrease in urate level by ~0.6-fold compared to unsupplemented cultures (Fig. 2.3B). This
decrease in urate level is consistent with reduced Xdh activity and it mimics that induced in cells
grown with trimethoprim. In accord with the second expectation that inhibition of Xdh would
result in xanthine accumulation, cellular levels of xanthine were found to increase ~2-fold,
equivalent to the increase observed on addition of trimethoprim. By comparison, addition of 2 mM
xanthine to the media resulted in a <1.5-fold increase in cellular xanthine (Fig. 2.3C).
The relative transcript levels of malR and malA were measured in cells grown with or
without allopurinol. The expression of malA and malR increased by ~43-fold and 11-fold,
respectively (Fig. 2.3D), similar to cells grown with trimethoprim (Fig. 2.1E). Addition of
allopurinol changed the pH of the media from 6.89±0.03 to 7.54±0.03 (Fig. 2.4A). In order to
ensure that the change in transcript level was not due to a change in pH (allopurinol was dissolved
in 0.4 M NaOH), an equivalent volume of 0.4 M NaOH was added to the control culture. When
only NaOH was added to the media, the pH of the media also increased (to 7.53±0.04; Fig. 4A)
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and no significant change in expression of malA or malR was seen (Fig. 2.4). This outcome
indicates that the change in malA and malR expression is due to allopurinol and not to changes in
pH, and that inhibiting Xdh activity leads to overexpression of both genes.

Figure 2.4. No change in mRNA level on addition of NaOH. The transcript levels were
calculated using 2-ΔΔCT relative to the reference gene and reported relative to expression in the
corresponding unsupplemented (2×YT) cultures.

Increase in pH promotes trimethoprim sensitivity
Adding NaOH or allopurinol to the media modestly increased the pH, whereas
trimethoprim addition did not alter the external pH (Fig. 2.5A). In E. coli, an increase in pH leads
to more efficient uptake of trimethoprim as evidenced by a slower growth rate and an increased
effect of trimethoprim [35]. If such were the case in B. thailandensis, then adding trimethoprim
along with NaOH should result in slower growth rate as well as increased expression of malA and
malR. To examine if the slight change in pH was sufficient to increase uptake of trimethoprim in
B. thailandensis, cells were grown at low (15 µM) and high (30 µM) concentration of trimethoprim
with or without NaOH added. We found that growth of the bacteria at low concentration of
trimethoprim with NaOH added to the media is similar to its growth at the higher concentration of
trimethoprim, consistent with increased uptake of trimethoprim at elevated pH (Fig. 2.5B).
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Moreover, expression of malR and malA increased ~159 and 21-fold, respectively, when
trimethoprim (25 µM) was added along with NaOH to the growth media (Fig. 2.5C). This change
in expression of malA and malR seen upon addition of trimethoprim with NaOH was significantly
greater compared to that observed upon addition of trimethoprim only. We also note that adding
trimethoprim with NaOH imposed a further slight decrease in the cellular urate concentration
(~0.5-fold; Fig. 2.5D) compared to trimethoprim only (~0.6-fold). We infer that uptake of
trimethoprim by B. thailandensis is more efficient at higher pH and that the expression of malA
and malR is affected by trimethoprim in a concentration dependent manner.

Figure 2.5. Alkaline pH increases trimethoprim sensitivity. (A) Measurement of pH upon addition
of allopurinol (Allo; dissolved in NaOH), NaOH, or trimethoprim (Tri) to the growth media
(2×YT). (B) Increase in pH leads to slower growth rate in cultures supplemented with
trimethoprim. Growth was measured in 2×YT without or with NaOH added (light and dark blue),
in cultures containing 15 µM trimethoprim without or with NaOH added (Tri15; light and dark
orange) or 30 µM trimethoprim without or with NaOH added (Tri30; light and dark grey). (C)
Cells grown with trimethoprim and NaOH show increased upregulation of malA and malR
compared to cultures grown with trimethoprim only. The transcript levels were calculated using 2ΔΔC
T relative to the reference gene and reported relative to expression in the corresponding
unsupplemented (2×YT) cultures. (D) Relative cellular urate content in cells grown with
trimethoprim (Tri) without or with NaOH added. Data represent mean ± SD from three
independent experiments. Asterisks indicate statistically significant differences relative to
unsupplemented cultures, except where bracket indicates otherwise (**, p<0.01; *, p<0.05).
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Xanthine is involved in trimethoprim-mediated gene regulation
The Xdh inhibitor allopurinol elicited a similar effect as trimethoprim in terms of
upregulation of malR and malA (Figs. 2.1E and 2.3D) with corresponding increases in intracellular
xanthine concentrations (Fig. 2.3B). In some bacterial species, xanthine has been reported to
induce an increase in expression of the genes encoding Xdh [36, 37], so we wanted to ascertain if
growth with allopurinol or trimethoprim led to changes in xdh expression. Both allopurinol and
trimethoprim caused modestly (<2-fold) increased expression of xdh a change in expression also
seen on addition of xanthine (Fig. 2.6A), further indicating that trimethoprim and allopurinol elicit
similar changes in purine metabolism. When trimethoprim was added along with NaOH, an ~4fold upregulation in xdh expression was observed, which speaks to a concentration-dependent
effect considering the facilitated uptake of trimethoprim at the slightly more alkaline pH. By
comparison, a mixture of allopurinol and trimethoprim (5 mM and 30 µM, respectively) led to an
~5-fold increased expression of xdh. Notably, this elevated level of xdh expression corresponded
to a 2.5-fold higher cellular level of xanthine compared to an ~2-fold increase with either
trimethoprim or allopurinol alone (Fig. 2.3C) and to a high level of expression of both malA (~162fold) and malR (~21-fold; Fig. 2.6B) that is comparable to that seen with trimethoprim and NaOH
(Fig. 2.5C).
The transcription factor MftR controls expression of ~400 genes in B. thailandensis, and
its DNA binding is attenuated on binding of the ligands urate or xanthine [16, 38]. This raises the
possibility that MftR participates in controlling gene expression in response to accumulation of
intracellular xanthine. The gene encoding MftR is divergent to mftP, which encodes the efflux
pump MftP; MftR binds the mftR-mftP intergenic region, causing repression of both genes, and
urate induces expression of mftP in a concentration-dependent manner, with increased expression
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observed when 5 mM urate was added to the media [16]. Accordingly, we would expect
upregulation of mftP only if intracellular xanthine levels reach a certain threshold. Consistent with
this expectation, upregulation of mftP is seen when cells are grown with trimethoprim and either
NaOH or allopurinol, conditions under which cellular xanthine levels are the highest (Fig. 2.6C).
Evidently, the efficiency of trimethoprim uptake correlates with cellular levels of xanthine, which
in turn elicit an upregulation of xdh and mftP, and with malA and malR expression.

Figure 2.6. Trimethoprim and allopurinol affect both xdh and mal gene expression. (A) Relative
xdh expression in cells grown with NaOH, allopurinol (Allo), trimethoprim (Tri),
trimethoprim+NaOH, trimethoprim+allopurinol, or xanthine (Xan) compared to cells grown in
2×YT. (B) Change in expression of malA and malR upon addition of trimethoprim and allopurinol
together. (C) Relative change in mftP transcript levels compared to cells grown in 2×YT. The
transcript levels were calculated using 2-ΔΔCT relative to the reference gene and reported relative to
expression in the corresponding unsupplemented (2×YT) cultures. Asterisks indicate statistically
significant differences relative to unsupplemented cultures, except where brackets indicate
otherwise (**, p<0.01; *, p<0.05).
MftR participates in controlling malR expression
In order to determine if MftR directly participates in controlling malR expression in vivo
we performed chromatin immunoprecipitation (ChIP). A B. thailandensis strain harboring C61

terminally FLAG-tagged MftR was created and expression of the tagged protein was verified by
Western blotting (data not shown). For ChIP, we used as a positive control the intergenic region
between mftR and the divergently oriented gene mftP to which MftR binds in vitro [20, 38], and
we verified MftR binding to this region in vivo (Fig. 2.7A). A negative control using the ohrR
upstream region to which the unrelated transcription factor OhrR binds [39] was used to ensure
the immunoprecipitation was specific, and no indication of MftR binding was detected (Fig. 6B).
The ability of MftR to bind upstream of malR was tested by amplifying a fragment comprising 74
bp upstream of malR and part of the coding region, and MftR was found to bind this region,
consistent with the notion that it directly controls malR expression (Fig. 2.7C).
We previously characterized a B. thailandensis ∆mftR strain and documented a markedly
increased expression of mftP, which was completely reversed on complementation with mftR [16].
As shown in Fig. 2.7D, mftP expression was >100-fold higher in the ∆mftR strain compared to
wild-type cells, and addition of trimethoprim had no further effect on mftP expression. By contrast,
expression of malA and malR were increased ~14-fold and 4-fold, respectively, in the ∆mftR strain
compared to wild-type cells, pointing to a role for MftR in controlling gene expression. A further
increase in expression of malA and malR was observed on addition of trimethoprim (~135-fold
and 16-fold, respectively, relative to the expression in wild-type cells without any supplements;
Fig. 2.7E-F). This translates into 10-fold and 4-fold higher expression of malA and malR in ∆mftR
cells on addition of trimethoprim (Fig. 2.6G). These trimethoprim-induced changes in gene
expression in ∆mftR cells were lower than those seen in wild-type cells grown with trimethoprim
(50-fold and 11-fold, respectively; Fig. 2.1E; note that measurements of mRNA levels in wildtype and ∆mftR cells were performed side-by-side in the same experiment). These observations
are consistent with MftR playing a role in trimethoprim-mediated induction of gene expression.
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Taken together, we infer that MftR participates in controlling malR (and in turn malA) expression
along with a second transcription factor, and that both repressors respond to metabolites produced
when cells are grown with trimethoprim.

Figure 2.7. MftR binds malR and affects its expression. (A-C) In vivo binding of MftR determined
by chromatin immunoprecipitation. PCR products electrophoresed on 1.5% agarose gels and
visualized with ethidium bromide for mftR-mftp intergenic region to which MftR binds in vitro
(A), ohrR promoter, which is not regulated by MftR (B), and malR (C). Results are representative
of three biological replicates. L, 100 bp ladder (at the left, in bp); IC, input control; NC, negative
control without antibody; IP, immunoprecipitated with anti-FLAG antibody. (D-F) Relative
changes in mftP, malA, and malR transcript levels, respectively, in mftR cells grown without or
with trimethoprim (Tri) compared to cells grown in 2×YT. The transcript levels were calculated
using 2-ΔΔCT relative to the reference gene and reported relative to expression in wild type cells
grown in 2×YT. Asterisks indicate statistically significant differences relative to unsupplemented
wild-type cultures, except where brackets indicate otherwise. (G) Increase in expression of malA
and malR induced by addition of 25 µM trimethoprim to mftR cells in liquid culture. Asterisks
indicate statistically significant differences relative to unsupplemented mftR cultures (**,
p<0.01).
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Trimethoprim increases virulence of B. thailandensis
It has been previously reported that expression of the mal gene cluster is critical for both
B. pseudomallei and B. thailandensis to infect C. elegans [22, 24]. It has also been demonstrated
that trimethoprim elicits production of malleilactone [12]. One would therefore expect that
trimethoprim-mediated over-production of malleilactone would affect the ability of B.
thailandensis to infect C. elegans. To determine if the upregulation of malA is physiologically
relevant, a survival assay was conducted using C. elegans as the model organism. It is to be noted
that C. elegans has been shown to be unaffected by 1 mM trimethoprim [40], which is a much
higher concentration compared to what we utilized for our experimental purpose. We observed a
difference between B. thailandensis grown on plates containing a sub-lethal dosage of
trimethoprim (25 M) and those grown on regular NGM plates; approximately 80% of the C.
elegans died when co-incubated with B. thailandensis on plates containing trimethoprim compared
to only 20% death of C. elegans when co-incubated with cells on NGM plates containing DMSO
after a 24 hour incubation (Fig. 2.8A). While C. elegans incubated with B. thailandensis looked
sicker and exhibited reduced mobility compared to those incubated with E. coli OP50, only worms
that were completely insensitive to touch and unable to maintain their normal body posture were
considered as dead (Fig. 2.8 B-C). After prolonged incubation, all C. elegans died on incubation
with B. thailandensis, regardless of the presence of trimethoprim (data not shown) [41]. By
contrast, worms deposited on plates seeded with E. coli XL1-Blue transformed with plasmid
pSCrhaB2, which confers resistance to trimethoprim, remained healthy whether or not
trimethoprim was added to the media.
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Figure 2.8. Survival of C. elegans. (A) Survival of C. elegans co-incubated with E. coli OP50
(gray bar), B. thailandensis (blue bar), B. thailandensis grown with 25 m trimethoprim (Tri;
orange bar). E. coli XL1-Blue(pSCrhaB2) (XL-B; gray striped bar), or E. coli XL1Blue(pSCrhaB2) grown with 25 m trimethoprim (XL-B/Tri; gray/orange striped bar) on NGM
plates at room temperature for 24 hours (mean ± SD). Asterisks indicate statistically significant
differences ((**, p<0.01) (B) Live C. elegans being able to maintain its body posture on plate
containing B. thailandensis with DMSO. (C) Dead C. elegans insensitive to touch and unable to
maintain its regular body posture on plate containing B. thailandensis with trimethoprim.
DISCUSSION
MftR represses malR expression
MalR is an essential activator of the mal gene cluster [22]. It also appears evident that the
increased malleilactone production characteristic of cells grown with trimethoprim is due to an
effect on malR expression, with MalR in turn activating the mal genes [15]. In addition to MalR,
the LysR-type transcriptional regulator ScmR also participates in controlling mal genes by
repressing gene expression in an acyl-homoserine lactone-dependent fashion [42, 43]. While
deletion of the ∆scmR gene leads to increased production of malleilactone, no effect on malR
expression was seen in ∆scmR cells [42]. An explanation that would be consistent with these
observations is that the activator MalR and the repressor ScmR compete for binding to the mal
gene promoter (Fig. 2.9A). In support of these interpretations, the already high levels of
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malleilactone produced in ∆scmR cells are even greater after addition of trimethoprim, suggesting
that the trimethoprim-mediated induction of malleilactone production is independent of ScmR
[15].
Upregulation of numerous biosynthetic gene clusters, including malR and mal, was
previously shown by RNA-seq in B. thailandensis deleted for mftR and in wild-type cells grown
with the MftR ligand urate [16]. We show here that MftR binds the malR promoter in vivo (Fig.
2.7C), and that malR expression is increased in ∆mftR cells and in cells grown in presence of the
MftR ligand xanthine (Figs. 2.3A and 2.7F). Consistent with the increased malR expression, malA
is upregulated accordingly. This indicates that MftR contributes to repression of malR expression.
Addition of trimethoprim elicits an increase in malR expression, and this increase is even
greater in ∆mftR cells (Figs. 2.1E and 2.7E-F). This observation also points to repression of malR
by MftR, and it indicates that the malR gene is repressed by both MftR and by a second repressor
(Fig. 2.9B). Trimethoprim does not bind MftR [16], and it has also been demonstrated that
accumulation of secondary metabolites requires inhibition of DHFR and not trimethoprim per se
[15], indicating that it is metabolites accumulating as a consequence of trimethoprim-mediated
inhibition of DHFR that induce malR. Since deletion of scmR has no effect on malR expression,
the second repressor is unlikely to be ScmR. The possibility that malR is autoregulated by MalR
has not been explicitly reported, however, the identified Lux-box to which MalR binds is far from
the malR gene and therefore less likely to be part of the malR regulatory sequence. The identity of
the second repressor notwithstanding, both MftR and the second repressor apparently respond to
metabolites that accumulate when DHFR is inhibited by trimethoprim. The genomic locus
comprising malR and the mal gene cluster as well as mftR are conserved in the pathogenic strains,
suggesting a similar mode of MftR-regulated control of malR expression in these strains.
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Fig. 2.9. Regulation of the mal gene cluster. Intergenic region between the divergently encoded
malR (blue) and malA (green) is shown. The Lux-box to which MalR binds is identified as a green
line. (A) A competition between the activator MalR (blue) and the repressor ScmR (yellow) for
binding to the malA promoter is illustrated; deletion of scmR results in increased mal expression.
(B) Repression of malR by MftR (grey) and a second repressor (brown); in absence of MalR
production, ScmR represses mal expression efficiently (top panel). Addition of trimethoprim
results in inhibition of DHFR and the attendant accumulation of specific metabolites such as
xanthine (red oval). These metabolites act to induce expression of malR, presumably by binding
directly to both MftR and the second repressor and attenuating their DNA binding. As a
consequence, MalR activates mal expression and outcompetes binding and repression by ScmR
(bottom panel).
Modulation of purine homeostasis by trimethoprim is linked to changes in gene expression
Trimethoprim blocks DHFR activity, thereby preventing the NADPH-dependent reduction
of dihydrofolate to tetrahydrofolate (THF), which supplies 1C units for various reactions, such as
the synthesis of glycine, methionine, thymidine triphosphate (dTTP), and purines [19, 35, 44].
Such inhibition leads to accumulation of pathway intermediates; de novo purine biosynthesis
generates inosine monophosphate (IMP; Fig. 2.2A), which can then be converted to either ATP or
GTP, but inhibition of DHFR leads to accumulation of the intermediate AICAR instead of
production of IMP [19]. Under such conditions, purine salvage may be favored, including reducing
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the conversion of xanthine to urate, as urate formation siphons purines away from the salvage
pathway and precludes recycling. Increased purine salvage has also been reported during the
starvation-induced stringent response, another condition that disfavors de novo purine
biosynthesis, where upregulation of genes encoding Xdh is linked to production of the signaling
molecules guanosine 5′‐triphosphate‐3′‐diphosphate (pppGpp) and guanosine 5′‐diphosphate‐3′‐
diphosphate (ppGpp) [14, 30, 31]. Stringent response amplifies the effect of trimethoprim in B.
thailandensis, as evidenced by reduced malleilactone accumulation in cells deleted for enzymes
responsible for synthesis of (p)ppGpp [15].
Our data are consistent with increased purine salvage in response to administration of
trimethoprim, as urate levels decreased significantly whereas xanthine accumulated (Fig. 2.5B-C).
The remarkable similarity in terms of both cellular urate and xanthine levels and malR/malA
expression in response to either trimethoprim or the Xdh inhibitor allopurinol identifies impaired
purine homeostasis as a key factor in the response to trimethoprim. Xanthine can be converted to
xanthine monophosphate (XMP) by hypoxanthine guanosine ribosyl transferase (HGPRT; Fig.
2.2A) and XMP can be aminated to generate GMP, which can then be converted to other
phosphorylated guanosine derivatives. GMP reductase catalyzes the reductive deamination of
GMP to IMP, which allows the synthesis of ATP. Since impaired dNTP homeostasis can affect
genome integrity and have genotoxic consequences [45], an imbalance in the dNTP levels could
occur if purine salvage were not tightly regulated and excess xanthine were readily converted to
XMP and in turn to GTP. Xdh is considered the rate-limiting enzyme in purine salvage where it
favors production of guanosine derivatives [46], and upregulation of genes encoding Xdh in
response to xanthine accumulation (Fig. 2.6A) would serve to avert such imbalance.
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Expression of malR/malA correlates with cellular xanthine levels. Allopurinol inhibits Xdh
and it causes both xanthine accumulation and an increased malR/malA expression, which directly
implicates impaired purine homeostasis in eliciting changes in gene expression. Since
trimethoprim is structurally unrelated to allopurinol, we consider it unlikely that it induces
xanthine accumulation by directly inhibiting Xdh activity. However, trimethoprim results in a
buildup of the purine precursor AICAR [19], and it is conceivable that this compound might
interfere with Xdh activity.
It was reported that growth of B. thailandensis with homoserine mimics the effect of
trimethoprim in terms of malleilactone production; using a malA promoter-lacZ reporter, this effect
was concentration-dependent, requiring 10 mM homoserine to elicit a similar increase in bgalactosidase activity as 30 µM trimethoprim [15]. Homoserine is a precursor in the biosynthesis
of methionine and other amino acids, and it accumulates ~2-fold on addition of trimethoprim to B.
thailandensis since the final step in the methionine biosynthetic pathway, the S-methylation of
homocysteine, is THF-dependent [15]. In E. coli, homocysteine, which is derived from
homoserine, is toxic and it perturbs branched-chain amino acid biosynthesis [47]. We must
therefore also consider the possibility that a vast excess of homoserine forces a conversion of
homocysteine to methionine to alleviate potential toxicity, and that this reaction reduces the
available pool of THF, adversely affecting other THF-dependent enzymes. Regardless of
mechanism, the observation that allopurinol elicits a similar increase in malR/malA expression as
trimethoprim leads us to favor the interpretation that impaired purine homeostasis plays a primary
role in trimethoprim-mediated induction of malR and in turn malA.
Our data show that a sub-lethal dosage of trimethoprim, which is in clinical use for the
treatment of Burkholderia infections, causes increased worm death after a 12 h incubation period
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(Fig. 2.8). Since trimethoprim causes production of malleilactone, and since malleilactone is
critical for virulence, we surmise that the observed increase in worm death is largely contributed
by the elevated production of malleilactone; however, we cannot rule out a contribution from other
gene products that accumulate due to the presence of trimethoprim. This scenario illustrates the
importance of proper administration of trimethoprim and adherence to treatment protocols.
Trimethoprim promotes accumulation of xanthine, which is a ligand for MftR. Since MftR
participates in expression of numerous genes, including genes involved in virulence, other genes
may be differentially expressed on account of trimethoprim-mediated changes in purine
homeostasis.
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CHAPTER 3
GLOBAL REGULATOR MFTR-MEDIATED VIRULENCE AND
ANTIBIOTIC RESISTANCE IN BURKHOLDERIA THAILANDENSIS
INTRODUCTION
Burkholderia thailandensis, a relatively non-pathogenic strain, has been used as a model
organism for studying virulence mechanisms of the pathogenic strains, B. pseudomallei and B.
mallei, due to its high genetic similarity with these strains. In addition, it has also recently emerged
as a source of novel secondary metabolites with antifungal, anti-tumor and antibacterial activities
[1-3]. B. thailandensis encodes 12 annotated Multiple Antibiotic Resistance Regulator (MarR)
homologs, which are conserved in the pathogenic strains as well, out of which MftR is one [4]. In
general, MarRs are transcription factors, which bind to the intergenic region between two
divergently oriented genes, with their binding sites often overlapping with -10 and-35 promoter
elements. Thus, binding of a MarR prevents access of RNA polymerase to the promoter region
and prevents transcription [5]. MarRs frequently serve as environmental sensors; upon change in
environmental conditions such as antibiotic stress, oxidative stress and host-pathogen interaction,
the binding of MarR to the DNA can be altered and derepression occurs [6].
MarR homologs have been characterized and studied in various bacteria such as
Deinococcus radiodurans (HucR), Dickeya dadantii (PecS), Pseudomonas aeruginosa (MexR),
and Xanthomonas campestris (OhrR) [7-11]. Further, some of the MarRs such as PecS (D.
dadantii), MgrA (Staphylococcus aureus), and MvfR (P. aeruginosa) have been reported to
function as master regulators [7, 12, 13]. MftR (Major facilitator transport regulator) has been
reported to serve as a global regulator in B. thailandensis. MftR belongs to the UrtR (Urate
responsive transcriptional Regulator) sub-family of wHTH (winged helix-turn-helix) family of
DNA binding protein. MftR has been reported to generally function as a repressor of various genes,
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as 331 genes are upregulated in a ∆mftR strain, including those involved in regulation of genes
involved in metabolic pathways, secondary metabolite production, and virulence [14]. Urate and
xanthine, products of purine metabolism, have been reported to serve as ligands for MftR [15, 16].
Binding of these ligands to the protein brings a conformational change in the protein and attenuates
its DNA binding ability [8, 16]. Urate is a potent anti-oxidant produced by a host’s xanthine
oxidase in the process of making ROS (reactive oxygen species) [17]. ROS are generated as a
primary line of defense by host cells in response to bacterial infection [18]. Thus, MftR could serve
as sensor of host-pathogen interaction using urate as an effector molecule. Upon considering the
aforementioned premise it can be presumed that MftR could play a vital role in regulating genes
essential for successful host colonization ultimately leading to bacterial infection. Based on the
above hypothesis I predict that a ∆mftR strain could be more virulent. Further, increased biofilm
formation observed in the ∆mftR strain along with an ability to survive better under anaerobic
conditions [14] could result in increased resistance to antibiotics in the ∆mftR strain.
Despite B. thailandensis being relatively non-pathogenic it is to be noted that on
comparison to pathogenic strains a number of genes encoding virulence factors such as type III
secretion system, quorum sensing components, cytotoxic secondary metabolites, and siderophores
are conserved [14]. In chapter 2, I have reported the role of MftR in regulation of genes encoding
proteins involved in production of the cytotoxic product malleilactone. Here I focus on the role of
MftR in siderophore production. Iron (Fe) is essential for various biological processes such as
respiration, photosynthesis, enzymatic processes and so on. Although Fe is abundant in nature, its
bioavailability is markedly reduced because its most common form Fe3+ is insoluble at
physiological pH. Moreover, in a host, Fe is bound to other proteins, which makes iron acquisition
systems a crucial requirement for bacterial growth [19, 20]. To overcome iron deficiency, most
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bacteria utilize the mechanism of producing iron chelating molecules, siderophores. Siderophores
are small metal-chelating molecules with high affinity for Fe(III), which are produced by almost
all bacteria and generally under iron limiting conditions [21]. The role of siderophores becomes
even more critical for pathogens who face a challenging low iron environment inside a host [22,
23]. In general, bacteria have multiple types of siderophore receptors and can produce more than
one type of siderophore. A large number of studies in various bacteria have revealed that
siderophores are essential for causing virulence [24]. Besides acting as an iron chelating molecule,
siderophores can serve an anti-oxidant role during host-pathogen interaction [25]. Siderophores
can also bind other essential metals such as Mn, Mo, Co and Ni and deliver it to the microbe [26].
Thus, understanding the mechanism of regulation of siderophore production could help us develop
tactics to lower the pathogenicity as well as viability of bacteria.
Burkholderia spp. encode more than one type of siderophore namely: ornibactin,
malleobactin, cepaciachelin, cepabactin, pyoverdine, and pyochelin. Ornibactin has been
characterized among members of the Burkholderia cepacia complex (Bcc), while the structurally
related malleobactin is produced by members of the Burkholderia pseudomallei complex (Bpc)
[27]. Production of both of these siderophores has been reported to be under the control of a local
regulator belonging to the family of ECF (extra cytoplasmic sigma factor) [28, 29]. Malleobactin
has been reported to be the major siderophore in B. pseudomallei whose production is under the
control of an activator named Mbas, an ECF [29]. Malleobactin is the only conserved siderophore
in B. mallei indicating its importance in a virulent strain. Further, malleobactin has been shown to
be able to remove iron from both transferrin and lactoferrin [30]. A genetic locus similar to the
one found in B. pseudomallei, comprising the genes encoding enzymes essential for production
and uptake of siderophore along with ecf, is conserved in B. thailandensis. Interestingly,
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upregulation of the genes encoding enzymes essential for production of malleobactin as well as
increased siderophore production has been reported in ΔmftR. Here I report that ECF, encoded by
ecf (BTH_I2427), is an essential activator for regulating the genes involved in encoding enzymes
essential for production of major siderophore, malleobactin, in B. thailandensis. My results show
that ecf is directly repressed by MftR and that ∆mftR is more virulent as indicated by decreased
survival of Caenorhaditis elegans and increased maceration of onion tissues.
EXPERIMENTAL PROCEDURES
Growth Media and Stock Solutions
Bacterial cells were grown in LB (Luria Broth) media. C. elegans assay was performed on
60 mm NGM (Nematode Growth Media) plates. C. elegans (Bristol strain N2) were maintained at
room temperature on NGM media with E. coli OP50 as the food source. For qRT-PCR
(quantitative Real Time PCR) cells were grown in LB media. An overnight culture was diluted
1:100 for subculture unless indicated otherwise. B. thailandensis E264 strain was obtained from
American Type Culture Collection (ATTCC). The ∆mftR strain in which the coding region is
disrupted by a transposon, was obtained from the Manoil lab [31].
Construction of ∆ecf
∆ecf was created as described previously [14]. Briefly, a 346 bp fragment of the ecf open
reading frame was amplified using the primers Ecf_ko_Fwd and Ecf_ko_Rev. The PCR product
was cloned into the suicide vector pKnockTc. The construct was transformed into E. coli sm10 λ
pir cells. For creating the ∆ecf strain, mating was performed by mixing the overnight culture of
sm10λpir with B. thailandensis at a 2:1 ratio (donor:recipient). The mixture was washed twice with
1 ml of LB and resuspended in 60 l of LB. The mixture was then spotted on an LB plate and
incubated at 37°C for 12 hours. The mating mixture was scraped off and resuspended in 1 ml of
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LB. Serial dilutions (up to 10-5) of the culture were made and transformants were selected on LB
agar plates containing 80 µg/ml of tetracycline and 15 µg/ml of gentamicin. To verify the ∆ecf,
PCR was conducted using ECF _veri_Fwd and Pknoc_tc_rev primers.
Pellicle and Biofilm Formation Assay
Pellicle and biofilm formation assays were conducted as previously described [32]. Briefly,
an overnight culture of wild type and ∆mftR strains were diluted to 1 ODU. 30 l of the diluted
culture was added to 3 ml of the LB media in a plastic tube and kept stationary at 37 degrees for
72 hrs. At the end of the incubation period, pellicle formation was visually observed. For
measuring the biofilm formation, the media was gently removed, and the tubes were washed with
water to remove planktonic cells. One ml of 0.1% crystal violet was added to the tube and gently
rolled around to ensure that the crystal violet spread evenly around the tube. After 15 minutes of
incubation, excess crystal violet was dumped off and the tubes were washed two times with water
to remove excess crystal violet. Tubes were then allowed to air dry and 1 ml of DMSO was added
to dissolve the visible crystal violet stain. The solution was then allowed to incubate at room
temperature for 15 minutes and OD was measured at 560 nm using a spectrophotometer. For
biofilm assays, the graph represents the mean value of two technical replicates of three independent
biological samples.
Swarming and Swimming Assay
Swarming assay was conducted as previously described [33]. For swarming assay, agar
plates (0.5% (wt/vol) of Difco Bacto-agar, 8 g/liter of Difco nutrient broth, 5 g/liter of glucose)
were prepared and allowed to dry at room temperature for 8-10 hours. An overnight culture was
diluted to OD600~1 and 1 µl of the culture was spotted at the center of the plate. Plates were
incubated at 37 degrees for 24 hours before taking the final image. Swimming assay was conducted
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in similar way as swarming assay except the agar plates were composed of 0.3% (wt/volume) of
Difco Bacto-agar, 10 g/liter of tryptone, and 5 g/liter of NaCl. For swimming assay, plates were
incubated for 48 hours before taking the final image. Results are representative of three biological
replicates.
CAS (Chrome Azurol S) Assay
Variation in amount of siderophores was detected by CAS assay, performed as previously
described [34]. Briefly, cells grown over night were diluted to OD600~0.6 and pellets were
collected by centrifuging at 13,000 RPM for 1.5 minutes. The supernatant was discarded, and cells
were resuspended in 20 l of LB and 10 l of the cells were spotted at the center of the CAS plate.
Plates were incubated at 37 degrees for 48 hours before taking the final image. Results are
representative of three biological replicates.
qRT-PCR
An overnight culture of B. thailandensis was sub-cultured in 50 ml LB media and grown
until OD600 reached ~0.6. Once cells reached the desired density, 1 ml of the cell culture was
pelleted and washed twice with autoclaved diethyl pyrocarbonate (DEPC)-treated water and stored
at -80 °C. RNA was extracted utilizing Monarch Total RNA Miniprep Kit (New England Biolabs,
Ipswich, MA) according to the manufacturer’s protocol. RNA was electrophoresed on agarose gels
to ascertain integrity and PCR was performed to verify absence of genomic DNA contamination.
For measuring gene expression, One-Step qPCR was performed using Luna One step universal
master mix (New England Biolabs). Data represent means (± SD) from biological duplicates (each
determined from technical triplicates) using the comparative CT method (2-ΔΔCT).
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Table 3.1. Primers used for qRT-PCR
Primers

Sequence (5' to 3')

ecf forward

TCGAGAACACCTACCACGC

ecf reverse

TCGATCAGCCAGTCGATGAG

arcA forward

TCCCAAGCCATCCCTGAAG

arcA reverse

CAGGTTGTGCATCTCGAGC

hgprt forward

CGAGAAGAAGCCCTCCACAT

hgprt reverse

TCGAACTCGAGCGGGAAATC

Chromatin Immunoprecipitation (ChIP) Assay
For ChiP, an overnight culture of B. thailandensis MftR-FLAG was diluted 1:100 in 50 ml
LB. Once the cells reached OD600~0.6, 1% formaldehyde was added to the flask, which was placed
on a shaker for 16 minutes to allow crosslinking to occur. The cell culture was then centrifuged at
3,500 RPM at 4 °C for 8 minutes and the supernatant was discarded. Cell pellets were washed
twice by adding 20 ml phosphate buffered saline (PBS) followed by another wash with 5 ml of
PBS and centrifuging at 3,500 RPM for 5 minutes. Finally, the pellets were resuspended in 1 ml
of PBS and the supernatant was removed after centrifuging at 13,000 RPM for one minute. Cell
pellets were stored at -80 °C. ChIP was performed as previously described with some
modifications [35]. Briefly, cells were suspended in 1 ml of lysis buffer with protease inhibitor
cocktail and placed on ice for 1 hour. Genomic DNA was sheared by sonicating 5 times at 35%
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output at 10 secs pulse with 1-minute gap in between. Cell/cell debris-free lysate was collected by
centrifugation at 13,000 RPM at 4 °C for 12 min and transferred to a clean tube. The lysate was
centrifuged for another 3 min and the final lysate was collected. The lysate was precleared using
protein G-Sepharose beads (GE Healthcare) to reduce non-specific binding to the beads. For
immunoprecipitation, 5 μl of anti-FLAG (M2; MilliporeSigma, Burlington, MA) antibodies was
used. Eluted DNA from ChIP samples or input DNA was analyzed by PCR (for primer sequences,
see Table 3.2). PCR products were electrophoresed on 1.5% agarose gels containing ethidium
bromide. Signal intensities from PCR data was quantified from the TIFF images by using ImageJ
software. Experiments were performed in triplicate
Table 3.2. Primers used for ChIP
Primers

Sequence (5' to 3')

mftP-mftR intergenic region chip forward

GAGCTGCGCGATCCATTAAC

mftP-mftR intergenic region chip reverse

TGCAGGAGAATTAAGCATGGG

ecf upstream forward

ATGATCGACGAGCGAAGTG

ecf upstream reverse

GAGGATCGGTAACGGTTTTG

ohrR upstream forward

GGTCGTCTCCCATCGTTTC

ohrR upstream reverse

GTCGTTCATGGCGAGATTTTC
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Removal of Antibiotic Resistance Cassette from mftR
The ∆mftR strain in which transposon T23 (ISlacZ-PrhaBo-Tp/FRT) was inserted in B.
thailandensis mftR (at genomic position 2719492, open reading frame location 4) was obtained
from the Manoil laboratory and grown on LB-agar plates with 50 µg/ml trimethoprim. Single
colonies were selected to verify correct insertion of the transposon. PCR was performed using
primers Mftr_Veri_Fwd and LacZ. Removal of the antibiotic cassette was performed as previously
described [36]. Briefly, Flp recombinase-encoding pFLPe4 plasmid was transformed into E.
coli RHO3 cells. For mating, 6-8 single colonies of E. coli RHO3 and B. thailandensis were
overlayed on LSLB (Low salt LB) plates containing 200 µg/ml DAP (2,6-diaminopimelic acid)
and incubated at 30 °C for 6 hours. Selection was done on LSLB/kanamycin (250 µg/ml) plates at
30 °C. To induce flp expression, selected colonies were streaked on LSLB/kanamycin/rhamnose
plates and incubated at 30 °C. Colonies sensitive to trimethoprim but resistant to kanamycin were
streaked on LSLB plates and grown at 37 °C to induce loss of the temperature-sensitive pFlpe4.
Removal of antibiotic cassettes was confirmed by PCR using primers Mftr_no cassette_Fwd and
MftR_no cassette_Rev.
Antibiotic Sensitivity Test
To determine the variation of resistance between the ∆mftRX strain (∆mftR with no
antibiotic cassette) and wild type, cells grown overnight were diluted to 1:100 in 50 ml LB media
and placed in a shaker at 37 °C till OD600 reached 0.6. Once cells reached the desired OD600 1ml
of the culture was collected in an Eppendorf tube. The cells were then serially diluted 10-fold till
final dilution of 1000-fold and were spotted on LB plates containing ampicillin, trimethoprim,
tetracycline, kanamycin. The plates were incubated at 37 °C for 24 hours before taking the final
image.
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Table 3.3. Primers used for verification of ∆s
Primers

Sequence (5' to 3')

Ecf_ko_Fwd

GCTCTAGAGTGAAGCTCGTCGATTTCCC

Ecf_ko_Rev

GCGGTACCCGTCGCGGACCATGAAAT

ECF _veri_Fwd

AGACGCTCGTGCATTTCAT

ECF _veri_Rev

TTGCGGAGAACTGTGAATGC

Mftr_Veri_Fwd

GAGCACAGGACGCAGATTGA

LacZ

GGGTAACGCCAGGGTTTTCC

MftR_no cassette_ Fwd

GAGCACAGGACGCAGATTGA

Mftr_no cassette_Rev

ATGAGCTGCGCGATCCATTA

C. elegans Survival Assay
For assessment of ∆mftR strain virulence, 10 l of E. coli OP50 (control), wild type B.
thailandensis, and ∆mftR strains grown over night were spotted on NGM plates. Plates were
incubated at 37 °C for 24 hours and then allowed to equilibrate at room temperature for 12 hours.
At the end of the 12 hours period about 10-12 C. elegans were added to the plates and left for 12
hours at room temperature before checking for survival. Worms were observed under light
microscope (Olympus SZ-ST) for their ability to maintain body posture and sensitivity to touch.
Worms that were completely insensitive to touch and had lost their ability to maintain normal body
posture were declared as dead. The percentage of surviving worms was calculated as: Survival (%)
= (live worms/total worms used) × 100. The experiment was performed with three separate
biological samples, each in triplicate.
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Onion tissue maceration
Onion tissue maceration was performed as previously described [37]. Yellow onions
(Allium cepa) commercially available in grocery stores were utilized for the pathogenicity
experiment. Scale from the outer bulb was removed completely before cutting the bulb vertically,
to get long cylindrical scales, with a sterile razor. These scales were further cut to get uniform size.
About 10-12 autoclaved napkins were placed in a plastic container and sprayed with autoclaved
water to create a moist environment before introducing the onion slices. For this assay, wild type
or ∆mftR was grown overnight (18-20 hrs) on LB plates. Cells were then resuspended in LB to get
1010 CFU/ml of culture. The inner surface of individual scales was scraped gently with a sterile
pipette tip (1- to 10-μl volume) to remove the outer epidermal layer and create a wound. Ten μl of
bacterial culture (107 CFU/ml) was inoculated into the wound. The onion scales were incubated at
30°C for 72 hours. The degree of maceration was visually inspected, and images of individual
slices were taken. Cell free media (LB only) was used as control. The experiment was performed
with three separate biological samples of each strain.
RESULTS
Increased biofilm formation in ∆mftR
Biofilm has been reported as hallmark for chronic infection as bacteria growing in biofilm
not only evade host immune responses but can be resistant to a large number of drugs, creating an
obstacle in treatment of infection. Biofilm has been reported to be a major player in persistence of
P. aeruginosa and members of Bcc, which infect lungs of people with cystic fibrosis, in the airway
of CF patients [38, 39]. A common phenomenon associated to most biofilm is creation of a hypoxic
environment. Thus, successful establishment of persistent biofilm requires not only surface
attachment genes but also genes involved in anaerobiosis. Requirement of anaerobic fitness of
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pathogens for virulence and pathogenesis has been reported in various bacteria [40]. The ∆mftR
strain has been previously reported to grow better in anaerobic conditions compared to the wild
type. One of the key pathways involved for improved survival under anerobic condition is the
arginine deiminase (ADI) pathway [41]. Genes of the ADI pathway, arcDABC, are found across a
large number of bacteria. arcD, the first gene of the arcDABC operon, encodes an
arginine/ornithine antiporter (ArcD), and arcABC encodes the enzymes involved in anaerobic
degradation of arginine with concomitant production of ATP. Under anaerobic conditions, ArcD
helps for continuous operation of the ADI pathway via energy-efficient exchange of exogenous
arginine with endogenous ornithine [42]. To evaluate if the ADI pathway is upregulated in B.
thailandensis, relative expression of arcD was compared between wild type and ΔmftR. arcD
expression was increased by ~3.5-fold in the ΔmftR strain compared to wild type (Fig 3.1A).
Further, increased expression of arginine deiminase pathway has been reported in various bacteria
under biofilm formation [43]. To determine if biofilm formation ability is enhanced in ΔmftR, a
crystal violet staining assay was performed. After incubation for 72 hours a higher level of pellicle
biofilm (formed at air-liquid interference) was observed in the ∆mftR strain compared to the wild
type (Fig. 3.1B). Upon quantification, nearly 2-fold higher production of biofilm was observed in
the ∆mftR strain compared to wild type (Fig. 3.1C). Increased expression of arcD along with the
crystal violet staining assay suggests that ΔmftR strain can readily form more persistent biofilm
compared to wild-type cells.
Increased swimming and swarming motility in ∆mftR
Bacterial flagellar motility plays a key role in adhesion, biofilm formation, and
translocating virulent proteins. Swarming motility is considered as a precursor for biofilm
formation [44]. Since an increased biofilm formation was observed in the ΔmftR strain (Fig.3.1B)
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I assumed a variation could be seen in terms of motility between the wild type and the ΔmftR strain.
In order to determine if ΔmftR cells show variation in flagellar activity compared to wild type cells,
swimming and swarming motility assays were performed. Increased swimming and swarming
motility were observed in ΔmftR compared to wild type as indicated by increased swarm and
swimming diameter (Fig. 3.1 D and E). In case of B. pseudomallei it has been suggested that
flagella are important for invasion of macrophage as well as non-phagocytic cell lines. Moreover,
flagellum has been determined to be essential in B. pseudomallei during intranasal and
intraperitoneal infection of mice [45]. Thus, increased flagellar activity seen in ΔmftR along with
ability to survive better in anaerobic conditions suggests ΔmftR possesses increased virulence
characteristics.

Figure 3.1. Deletion of mftR leads to increased expression of ADI pathway genes, biofilm
formation, and motility. (A) Increased arcD expression in the ∆mftR strain compared to wild type.
(B) Pellicle formation in static culture. (C) Quantification of biofilm formation using crystal violet
staining. (D) Swimming (top) and (E) Swarming (bottom) motility.
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ECF is an essential activator for malleobactin production
Mbas, an ECF, has been previously reported to be an essential activator of malleobactin
production in B. pseudomallei [29]. In B. thailandensis a locus similar to that of B. pseudomallei,
encoding malleobactin along with an ecf is present. As stated earlier, the role of siderophore is
critical specially in pathogenic bacteria that encounter an iron limitation condition in the host
environment. To verify if ecf of B. thailandensis plays a similar role in malleobactin synthesis, a
∆ecf strain was created. To determine if ECF functions similar to MbaS or OrbS in regulating the
production of siderophore, a CAS assay was performed. As seen (Fig 3.2A), the amount of
siderophore produced in ∆ecf strain is reduced compared to wild type suggesting that ECF is an
essential activator for production of the siderophore malleobactin in B. thailandensis.

Figure 3.2. Variable malleobactin production in B. thailandensis ∆ strains. (A) Disruption of ecf
leads to decreased production of siderophore while in ∆mftR an increased production of
malleobactin is observed. The lower panel is the zoomed version of the plate to give a clear view
of the halo ring formed. (B) mftR mutation leads to increased expression of ecf.
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Previously, an upregulation of ecf was reported in the ∆mftR strain based on genome-wide RNAseq data [14]. Next, I compared the variation in siderophore production between the wild type and
the ∆mftR strain. The ∆mftR strain produces a larger orange halo ring indicating production of
more siderophore compared to wild type (Fig. 3.2A). Further, ecf is upregulated by ~ 4.5-fold in
∆mftR strain (Fig. 3.2B) The gene expression analysis along with CAS assay data not only shows
increased production of siderophore in ΔmftR, but it also indicates that MftR regulates ecf
expression.
MftR binds ecf regulating siderophore production
To determine if ecf is directly regulated by MftR, a ChIP-assay was performed. For ChIP,
the intergenic region between mftR and the divergently oriented gene mftP to which MftR binds in
vitro [15, 16] was used as the positive control, and I verified MftR binding to this region in vivo
(Fig. 3.3A). To ensure the obtained immunoprecipitation was specific, a negative control using the
ohrR upstream region to which the unrelated transcription factor OhrR binds [46] was used, and
no indication of MftR binding was detected (Fig. 3.3A). The ability of MftR to bind upstream of
ecf was tested by amplifying a fragment comprising 128 bp upstream of ecf and part of the coding
region, and MftR was found to bind this region (Fig 3.3B). Our ChIP data is consistent with the
gene expression analysis and siderophore production assay supporting the notion that MftR binds
to the upstream region of ecf directly regulating its expression. Thus, our data indicate that ECF is
an activator of the genes involved in encoding enzymes essential for malleobactin production and
transport and its expression is directly regulated by MftR.
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Figure 3.3. MftR binds ecf directly. (A and B) In vivo binding of MftR determined by chromatin
immunoprecipitation. PCR products electrophoresed on 1.5% agarose gels and visualized with
ethidium bromide for mftR-mftp intergenic region to which MftR binds in vitro (A), ohrR
promoter, which is not regulated by MftR (A), and ecf (B). Results are representative of three
biological replicates. L, 100 bp ladder (at the left, in bp); IC, input control; NC, negative control
without antibody; IP, immunoprecipitated with anti-FLAG antibody.
∆mftR is more virulent
My data so far clearly indicates that the ∆mftR strain demonstrates various physiological
characteristics generally associated with virulence. Moreover, in chapter 2 I have reported that
MftR along with an unknown transcription factor directly regulates malR, encoding MalR. MalR
is an essential activator of the mal gene cluster which encodes enzymes essential for production of
the cytotoxic compound malleilactone. Production of malleilactone is essential for killing of C.
elegans by B. thailandensis. Combining the characteristics described above with the production of
malleilactone led us to hypothesize that disruption of mftR could make cells more virulent towards
C. elegans. In order to test this hypothesis, a C. elegans survival assay was conducted.
Approximately 60% of the C. elegans died when co-incubated with ∆mftR cells compared to only
20% death of C. elegans when co-incubated with wild type cells on NGM plate (Fig 3.4).
Several species in the genus Burkholderia have been known to cause rotting in onions but
no such effect has been reported for B. thailandensis [37, 47]. Since genes involved in production
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of various secondary metabolites are upregulated in ∆mftR cells and since pathogenic
characteristics (increased biofilm formation, motility and siderophore production) is a hallmark of
the ∆mftR strain I presumed a possibility that it could be successful in causing rot in onion. To test
this hypothesis, onion scales were wounded and incubated with wildtype or ∆mftR cells. Upon
infecting onion wounds with wild type cells and ∆mftR cells a significantly higher area of
maceration for the ∆mftR strain compared to wild type was observed (Fig. 3.4 B and C). Thus, it
can be concluded that the ∆mftR strain is virulent in both animal and plant models utilized.

Figure 3.4. ∆mftR is more virulent than wild-type cells. (A) Survival of C. elegans co-incubated
with E. coli OP50 (gray bar), B. thailandensis (blue bar), or ∆mftR (red bar) on NGM plates at
room temperature for 24 hours (mean ± SD from three independent experiments). Asterisks
indicate statistically significant differences between wild-type and mftR cells ((**, p<0.01).
Increased maceration observed in onion scales when incubated with the ∆mftR strain (B and C).
Maceration observed in the outermost scale underneath the tunic (B) and the second layer of scales
(C) after 72 hours of coincubation with LB (control), wildtype and ∆mftR.
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∆mftR is more resistant to ampicillin and kanamycin
The ability of ∆mftR to readily form biofilm and to survive better under anaerobic
conditions, along with upregulation of various efflux pumps, could potentially make it more
resistant to antibiotics compared to wild type. To test if MftR could play a direct or indirect role
in antibiotic resistance, an antibiotic sensitivity test was conducted with different classes of
antibiotics (ampicillin, kanamycin, trimethoprim and tetracycline). ∆mftRX (∆mftR with no
antibiotic cassette) showed increased resistance against kanamycin and ampicillin. MftR directly
regulates mftP, encoding MftP, whose substrate is still unknown. Upregulation of mftP in ∆mftR
has been previously reported. The increased resistance of ∆mftR to ampicillin or kanamycin raises
the possibility of these antibiotics being substrates for MftP.

Figure 3.5. mftR deletion alters resistance to antibiotics (A) LB, ( B) Kanamycine (75 µg/ml),
and (C) Ampicillin (20 µg/ml)

DISCUSSION
For successful survival and multiplication in a hostile host environment, bacteria require
mechanisms to sense the change in the environmental conditions and to counteract the host
defense. The role of MarR family proteins in regulation of genes involved in cellular response,
oxidative stress, antibiotic resistance, and virulence in response to change in environmental
conditions has been characterized in various bacteria [4, 48]. One of the preliminary steps required
for host-pathogen interaction is successful attachment of the bacterial cell to the host. Flagella not
only help chemotaxis movement to avoid harsh conditions but also help in successful adhesion to
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the host surface. Studies in various bacteria have revealed that defects in flagellar protein lead to
bacteria becoming less virulent or unable to infect a host [45, 49]. In B. cenocepacia, flagella have
been reported to play an important role in virulence in a murine agar bead model of infection [50].
The experimental data reported here shows that ∆mftR has increased flagellar motility (Fig 3.1 D
and E).
Secondly, successful colonization of the host would require a mechanism to avoid host
defense, oxidative stress, and antibiotic stress. One of the well-studied mechanisms that a large
number of bacteria employ for successful colonization and survival in host is biofilm formation.
Biofilm not only provides resistance against changes in pH, osmolarity, and nutrients scarcity but
also against antibiotics and it helps the bacteria evade the host immune system [51]. Due to the
anoxic environment created in a biofilm, genes involved in anaerobiosis play a critical role in
establishment of persistent biofilm. ∆mftR survives better in an anaerobic environment compared
to wild type [14] and arcD upregulation (Fig. 3.1 A), involved in anaerobiosis, would be expected
to promote the ability of ∆mftR to form a persistent biofilm. Moreover, it has been reported that
Burkholderia spp. grown under anaerobic conditions have increased resistance against antibiotics.
The study also reported that drug-tolerant cells were characterized by an anaerobic metabolic
signature [40, 52]. I observed that ∆mftR shows not only increased biofilm formation (Fig 3.1 B
and C) but also increased antibiotic resistance against kanamycin and ampicillin (Fig 3.5 B and
C). The antibiotic resistance observed in ∆mftR needs to be further analyzed. MftR directly
regulates mftP, encoding MFTP, whose substrate has not been determined yet. Gene expression
analysis of mftP in the presence and absence of these antibiotics along with susceptibility test of
cells deleted for mftP would help to determine if MftR plays a direct role in resistance against these
antibiotics via regulating mftP or is indirectly involved through upregulating other genes.
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For bacteria, especially pathogenic ones, to survive in a host environment, an efficient iron
acquisition mechanism is critical [53]. Burkholderia spp. encode more than one type of
siderophore but in case of the pathogenic B. mallei the only known siderophore is malleobactin.
Here, I have reported that an ECF (encoded by Bth_I2427), like Mbas, is an essential activator of
the genes involved in malleobactin production and uptake. Ornibactin, structurally related to
malleobactin, has been shown to be essential for B. cenocepacia to cause infection in C.
elegans and Galleria mellonella [54]. Further, ecf is directly under the control of MftR as shown
by ChiP (Fig 3.3 C) and further supported by the increased expression of ecf (Fig. 3.2 B) and the
increased siderophore production (Fig. 3.2A) observed in ∆mftR. A C. elegans or G. mellonella
survival study in ∆ecf could help shed light on the role of malleobactin in survival and
pathogenicity in members of Bpc.
B. thailandensis possesses the ability to kill C. elegans. Although B. thailandensis encodes
a large number of secondary metabolites, malleilactone has been reported to be an essential
compound required to cause infection and death in C. elegans [55]. In chapter 2, MftR was shown
to directly regulate malR, encoding MalR. Further, upregulation of malA and malR in ∆mftR has
also been reported. Bactobolin, a cytotoxic polyketide-peptide, has also been reported as an
important pathogenic toxin utilized by B. pseudomallei to cause infection in C. elegans [56].
Upregulation of genes involved in production of bactobolin (>20- fold) as well as increased antibacterial ability has been reported in ∆mftR [14]. Upregulation of cytotoxic compounds along with
increased pathogenic traits is indicative of MftR-mediated regulation of virulence genes in B.
thailandensis. The C. elegans survival assay showed increased killing of worms when coincubated with ∆mftR indicating increased production of cytotoxic compounds. Further, the mftR
caused increased maceration of onion tissue, which could also be a result of accumulation or over

94

production of cytotoxic compounds in this strain. Thus, based on results of both the invertebrate
and plant models utilized (Fig. 3.4 A, B, and C) it can be established that MftR plays a significant
role in regulation of virulence in B. thailandensis.
CONCLUSION
MftR, a MarR homolog, has been reported to be a global regulator in B. thailandensis.
Differential regulation of genes involved in metabolic pathways, secondary metabolite production
and pathogenicity in ∆mftR was reported in a genome wide RNA-seq study. Further, MftR is
conserved in the related pathogenic strain implicating a similar mode of regulation in the virulent
strains. The data so far shows that MftR is involved in regulation of biofilm formation, motility,
siderophore production as well as antibiotic resistance. Further, the role of MftR in production of
bactobolin and the cytotoxic compound, malleilactone, has been discussed earlier in chapter 1 and
2 respectively. The data obtained so far indicate that ∆mftR not only displays virulent phenotypic
characteristics but plays a critical role in pathogenesis of B. thailandensis.
.
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CHAPTER 4
CONCLUSION/FUTURE OUTLOOK
CONCLUSION
Burkholderia thailandensis, a relatively non-pathogenic strain, has served as a model
organism for the study of pathogenic strains, namely B. pseudomallei and B. mallei, due to its high
genetic similarity with these strains [1]. The recent discovery that the B. thailandensis genome
features a large number of biosynthetic gene clusters, encoding enzymes essential for production
of secondary metabolites, has added another dynamic of focus on B. thailandensis as a source for
production of novel compounds. These biosynthetic gene clusters that encode enzymes responsible
for production of secondary metabolites, whether virulence factors or novel compound with
potential clinical activity (antifungal, anti-cancer, antibiotics), generally remain silent under
normal growth conditions [2]. Bacterial secondary metabolites confer a competitive advantage to
bacteria in a hostile environment, yet the mechanisms by which their production is regulated has
not be been deciphered completely. Understanding how expression of these gene clusters could be
elicited would help shed light on mechanisms of pathogenicity as well as aid in the discovery of
novel beneficial compounds. Various strategies such as variation in growth media, alternation of
pH, and antibiotic stress have been utilized to elicit the expression of these secondary metabolites.
Unfortunately, local regulation of the biosynthetic gene clusters differs from one another creating
a hurdle in discovery of overall secondary metabolites synthesized by the bacteria [3]. The recent
discovery that global regulators, MftR and ScmR, play a critical role in regulation of a large
number of biosynthetic gene clusters in Burkholderia has opened a new path for eliciting
production of secondary metabolites through modulation of global regulators [4, 5]. Concurrently,
in B. thailandensis, a sub-lethal dosage of trimethoprim has been identified as a potent elicitor of
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these biosynthetic gene clusters, however, the molecular mechanism by which trimethoprim causes
change in gene expression was not delineated [4].
The first chapter in this dissertation describes the importance of secondary metabolites and
describes some of the well-known secondary metabolites produced by B. thailandensis. The B.
thailandensis genome includes ~22 natural product biosynthetic gene clusters, potentially involved
in production of novel compounds [6]. The chapter not only describes the function of the secondary
metabolites and various local regulators involved in production of these secondary metabolites,
but it also describes the role of global transcriptional regulators in regulating production of these
secondary metabolites. Further, the observation that a sub-lethal dosage of trimethoprim is an
elicitor of biosynthetic gene clusters has been briefly described. Compounds accumulated under
the effect of trimethoprim and genes upregulated in Δmftr strain has staggering similarity. The
mechanism by which trimethoprim causes upregulation of various secondary metabolites similar
to global regulator MftR is considered in the second chapter. Thus, the first chapter in general
describes some of the important secondary metabolites present in B. thailandensis with emphasis
on alternative paths for unlocking the production of secondary metabolites through targeting global
regulators.
The second chapter provides a mechanism of trimethoprim-based upregulation of
secondary metabolites in B. thailandensis. Although a striking similarity between the compounds
accumulated under sub-lethal dosage of trimethoprim and genes upregulated in ΔmftR has been
reported, MftR is not a direct target of trimethoprim [5]. In order to disentangle this convoluted
situation, my work focused on regulation of the genes involved in regulation of genes comprising
the mal gene cluster, encoding enzymes essential for production of malleilactone. Malleilactone,
a cytotoxic product known to be an important virulence factor, is accumulated under sub-lethal
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dosage of trimethoprim. My work shows that malR, encoding an essential activator (MalR) of the
mal gene cluster is under direct control of MftR. Further, a previously unreported consequence of
sub-lethal dosage of trimethoprim causing disturbance in the purine metabolism pathway has been
demonstrated. The result of this phenomenon is accumulation of xanthine, a ligand for the global
regulator MftR, causing increased expression of malR and ultimately the mal gene cluster.
Allopurinol, a Xdh inhibitor, led to similar upregulation of malR and the mal gene cluster, which
indicates that disturbance in the purine pathway indeed leads to increased expression of virulence
factors. Lastly, an increased killing of C. elegans upon coincubation with bacterial cells grown
with trimethoprim puts forth a grave situation of increased virulence under sub-lethal dosage of
antibiotics.
The third chapter describes the virulent phenotype observed upon disruption of the mftR
gene. In ΔmftR, increased biofilm formation, motility, and siderophore production, which aid in
increased virulence, was observed. Moreover, my work shows that ecf, encoding ECF – an
essential activator for malleobactin synthesis – is directly under the control of MftR. Taken
together all these features along with the increased production of malleilactone (described in
Chapter 2) indicate ΔmftR cells to be more virulent. An increased killing of C. elegans and
increased maceration observed in onion scales when co-incubated with the ΔmftR strain helps to
confirm it to be more virulent than wildtype. Moreover, an increased resistance against ampicillin
and kanamycin was observed in the ΔmftR strain. Thus, in overall this chapter emphasizes the role
of global regulator, MftR, in not just pathogenicity but also in antibiotic resistance.
FUTURE OUTLOOK
The need for novel effective antibiotics is greater today than ever and bacterial secondary
metabolites have for a long time been a source for their discovery. My dissertation has emphasized
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that identifying global regulators in different bacterial species through a combination of genomewide transcriptomics, metabolomics, and ChIP-Seq could increase our chances of discovering
novel compounds with not just antibacterial, but various other beneficial effects. Moreover, these
global regulators could be a novel drug target against pathogenic strains.
Co-trimoxazole, (a cocktail of trimethoprim and sulfamethoxazole) is often prescribed to
treat glanders and melioidosis [7]. My work shows that a sub-lethal dosage of trimethoprim leads
to increase in virulence via modulating purine metabolism pathway. That a sub-lethal dosage of
antibiotic leading to increased virulence is a grave scenario as an incomplete regimen of prescribed
medicine could lead to a harmful effect. This unintended consequence of increased virulence in
bacteria upon treatment with sub-lethal dosage of an antibiotic needs to be further explored. Such
studies will be helpful in determining an effective cocktail and dosage of drugs to be prescribed.
Secondly, accumulation of xanthine seen under effect of trimethoprim can have a clinical
significance as usage of trimethoprim could lead to xanthinuria. This could lead to a complicated
situation in people suffering from misregulated purine metabolism [8]. Inhibition of Xdh by
allopurinol led to accumulation of xanthine and similar changes in gene expression of malR and
malA as trimethoprim. This scenario raises a possibility that metabolites accumulated under the
effect of trimethoprim could causes inhibition of Xdh. Identification of this compound could help
in discovery of novel metabolites that could be utilized in patient suffering from gout diseases [9].
Purification of Xdh and conducting enzymatic activity assay with compounds accumulated under
the effect of trimethoprim could help achieve this goal. Further, computational modeling and
docking could help to shortlist possible compounds that could be tested against Xdh activity.
Lastly, a cocktail of trimethoprim and allopurinol was shown to further enhance the expression of
virulence genes. This outcome highlights that using trimethoprim to treat Burkholderia infections
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in persons prescribed allopurinol as gout medication, which inhibits Xdh, could have deleterious
outcome.
MftR is conserved in pathogenic strains, and it could be a drug target for treatment of
glanders and melioidosis. Based on the outcome of my third chapter, the increased virulence
observed in a ΔmftR strain helps to establish its roles in virulence. Ligands that target MftR,
outcompeting xanthine and urate, without altering it DNA binding ability can be an effective drug
target. Study focused on crystallization of MftR would be a leading step towards this approach. A
crystal structure of the protein bound with DNA and ligands could help us get a better
understanding of the important residues as well as the conformational changes the protein
undergoes. Such study could be followed up with computational modeling to help shortlist possible
compounds that can interact with the protein. Protein-DNA binding assay such as EMSA could
help determine if the compound selected could actually bind the protein without interfering with
its DNA binding ability.
The gene locus comprising mftR along with the mftp-fenI operon present is B. thailandensis
is conserved in pathogenic strains as well indicating its importance under different environmental
conditions. Thus, the role of mftP, identifying its substrate/s and function, could be an interesting
path to follow. That mftp is regulated by MftR [10] has been already demonstrated, and this study
could be effectively utilized in two ways: (1) Identifying the substrate effluxed by MftP along with
a combination of ligands that can bind MftR without altering its DNA binding ability could prove
to be a successful cocktail for treatment of melioidosis and glanders (2) Could the ligand for MftR
be a substrate for MftP or might a novel substrate for MftP, if identified, be a ligand for MftR.
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